intervention,"Active, not recruiting",Completed,Enrolling by invitation,Recruiting,Terminated,Total
placebo,100,88,15,351,22,576
standard care,20,47,5,111,7,190
hydroxychloroquine,21,29,6,49,25,130
convalescent plasma,17,26,3,64,2,112
azithromycin,9,9,6,20,3,47
saline,13,4,2,26,0,45
tocilizumab,6,12,0,21,4,43
ivermectin,0,16,0,23,0,39
remdesivir,4,8,0,22,2,36
favipiravir,11,3,0,21,0,35
mesenchymal stem cells,10,5,1,19,0,35
enoxaparin,2,0,0,27,1,30
ritonavir,2,6,2,18,1,29
blood sample,1,1,0,23,1,26
lopinavir,2,4,2,17,1,26
control,2,3,0,13,3,21
heparin,2,2,2,15,0,21
vitamin d,4,3,1,13,0,21
colchicine,0,3,0,17,0,20
inactivated sars-cov-2 vaccine,5,0,5,10,0,20
methylprednisolone,1,6,0,12,0,19
prone positioning,1,1,1,16,0,19
exercise,0,9,0,9,0,18
lopinavir/ritonavir,2,4,2,9,1,18
nitazoxanide,2,5,0,11,0,18
oxygen,5,1,0,11,1,18
vitamin c,2,5,0,10,1,18
chloroquine,1,4,0,7,5,17
dexamethasone,1,1,0,13,2,17
plasma,2,4,1,10,0,17
anakinra,1,2,0,8,5,16
interferon,1,6,1,8,0,16
questionnaire,0,1,1,12,0,14
povidone/iodine,0,5,0,8,0,13
serology test,1,2,1,8,0,12
telehealth,2,3,0,7,0,12
chadox1,5,0,0,6,0,11
hydroxychloroquine / azithromycin,3,4,2,1,1,11
nitric oxide,7,2,0,2,0,11
ruxolitinib,1,2,0,6,2,11
baricitinib,0,2,0,8,0,10
bcg,3,0,0,7,0,10
radiotherapy,2,1,0,7,0,10
sars-cov-2 rs,8,0,0,2,0,10
zinc,0,4,0,6,0,10
best available therapy,1,4,0,4,0,9
camostat mesilate,2,0,0,7,0,9
28-day schedule,0,0,4,4,0,8
cellectraâ® 2000,6,0,0,2,0,8
cholecalciferol,0,1,0,7,0,8
losartan,0,4,0,4,0,8
oseltamivir,1,0,0,7,0,8
three dose regimen,0,0,0,8,0,8
two dose regimen,0,0,0,8,0,8
biological samples,1,1,0,5,0,7
paracetamol,1,0,0,6,0,7
povidone-iodine,0,0,0,7,0,7
rivaroxaban,2,0,0,5,0,7
sarilumab,2,3,0,1,1,7
adjuvant,5,0,0,1,0,6
aspirin,0,0,1,5,0,6
best supportive care,1,3,0,2,0,6
bnt162b2,3,0,0,3,0,6
clazakizumab,3,1,0,2,0,6
dose) - stage 1,0,0,0,6,0,6
lenzilumab,2,0,0,4,0,6
mindfulness,0,2,0,4,0,6
nasal rinse,0,0,0,6,0,6
omega-3,0,0,0,6,0,6
pcr,0,0,0,6,0,6
plitidepsin,0,6,0,0,0,6
saliva,1,1,0,4,0,6
sars-cov-2 rs/matrix-m1 adjuvant,5,0,0,1,0,6
sofosbuvir,0,2,0,4,0,6
telmisartan,0,2,0,4,0,6
therapeutic plasma exchange (tpe),0,4,0,2,0,6
,0,3,1,1,0,5
ad26.cov2.s,3,0,0,2,0,5
adenovirus type 5 vector,3,0,0,2,0,5
arbidol,1,1,0,3,0,5
azd7442,1,0,0,4,0,5
biological,3,0,0,2,0,5
blood test,0,1,0,4,0,5
camostat,0,0,0,5,0,5
dalargin,0,4,0,1,0,5
famotidine,1,1,0,3,0,5
gam-covid-vac,3,1,0,1,0,5
kg,0,2,0,3,0,5
ly3819253,0,1,0,4,0,5
melatonin,1,0,0,4,0,5
mrna-1273,3,0,0,2,0,5
nigella sativa oil,0,0,0,5,0,5
nk cells,1,0,0,4,0,5
pulmozyme,0,0,0,5,0,5
regn10933,2,0,0,3,0,5
regn10987,2,0,0,3,0,5
supportive care,2,2,0,1,0,5
survey,0,0,0,5,0,5
14-day schedule,0,0,0,4,0,4
ace inhibitor,0,0,2,2,0,4
anticoagulation,0,0,0,3,1,4
atorvastatin,0,0,0,4,0,4
atyr1923,0,4,0,0,0,4
bacille calmette-guã©rin (bcg),0,0,0,4,0,4
behavioral intervention,0,0,0,4,0,4
bromhexine hydrochloride,1,1,1,1,0,4
budesonide,1,0,0,2,1,4
canakinumab,2,1,0,1,0,4
ciclesonide,0,0,0,4,0,4
daclatasvir,0,0,0,4,0,4
doxycycline,0,3,0,1,0,4
fluvoxamine,0,1,0,3,0,4
hyperbaric oxygen,0,0,0,3,1,4
mavrilimumab,2,0,0,2,0,4
mesenchymalÂ stem cells,0,1,0,3,0,4
n-acetylcysteine,0,0,0,4,0,4
na-831,0,0,2,2,0,4
nafamostat mesilate,0,1,0,3,0,4
nasopharyngeal swab,0,1,0,3,0,4
niclosamide,0,0,0,4,0,4
normal saline (0.9% sodium chloride solution) - stage 1,0,0,0,4,0,4
peginterferon,1,0,1,2,0,4
sargramostim,1,1,0,2,0,4
sodium,0,0,0,4,0,4
1200 mg),3,0,0,0,0,3
acalabrutinib,0,2,0,0,1,3
ag0302-covid19,3,0,0,0,0,3
anxiety reduction training,0,0,0,3,0,3
apixaban 2.5 mg,0,0,0,3,0,3
arb,0,0,0,3,0,3
atazanavir,0,0,0,3,0,3
ayurveda,0,3,0,0,0,3
bamlanivimab,1,0,0,2,0,3
bcg-denmark,1,0,0,2,0,3
behavior,0,0,0,3,0,3
blood,0,0,0,3,0,3
blood donation sms,0,1,2,0,0,3
bnt162b1,2,0,0,1,0,3
cannabidiol,2,0,0,1,0,3
cenicriviroc,0,0,0,3,0,3
chloroquine/hydroxychloroquine,0,0,0,3,0,3
clopidogrel,0,1,0,2,0,3
corticosteroid,0,0,0,3,0,3
cpap,1,0,0,2,0,3
cyclosporine,0,0,0,3,0,3
day,0,3,0,0,0,3
defibrotide,0,0,0,3,0,3
dose)- stage 2,0,0,0,3,0,3
dzif-10c,0,0,0,3,0,3
education,0,1,1,1,0,3
eidd-2801,0,2,0,1,0,3
emtricitabine,0,0,0,3,0,3
exhaled breath sampling,0,3,0,0,0,3
fostamatinib,1,0,0,2,0,3
gargle,0,0,0,3,0,3
had5-s-fusion,0,0,0,3,0,3
honey,0,1,0,2,0,3
immunoglobulin,0,1,0,2,0,3
information,0,0,2,1,0,3
ino-4800,2,0,0,1,0,3
iodine,0,0,0,3,0,3
low,1,0,0,2,0,3
ly3832479,0,0,0,3,0,3
mechanical ventilation,1,0,0,2,0,3
medium dosage inactivated sars-cov-2 vaccine on a 0-,0,0,1,2,0,3
menacwy,2,0,0,1,0,3
methylene blue,0,0,0,3,0,3
mf59 adjuvanted sars-cov-2 sclamp vaccine,0,0,0,3,0,3
monitoring visit,0,0,0,0,3,3
naltrexone,0,0,1,2,0,3
nutrition,0,0,0,3,0,3
phase 2,0,0,0,3,0,3
phone call,0,0,0,3,0,3
pirfenidone,0,0,0,3,0,3
prednisone,0,1,0,1,1,3
probiotic,0,0,0,3,0,3
quercetin,0,2,0,1,0,3
rapid test,0,1,1,1,0,3
ravulizumab,1,0,0,2,0,3
regn10933/regn10987 combination therapy,1,0,0,2,0,3
ribavirin,0,1,0,2,0,3
sevoflurane,0,0,0,3,0,3
sng001,1,0,0,2,0,3
stool collection,0,1,0,2,0,3
suspension of heat killed (autoclaved) mycobacterium w,0,1,0,2,0,3
tofacitinib,1,1,0,1,0,3
ty027,1,0,0,2,0,3
vir-7831,1,0,0,2,0,3
vitamin super b-complex,2,0,0,1,0,3
vpm1002,3,0,0,0,0,3
- tocilizumab,0,2,0,0,0,2
[18f]f-arag (2'-deoxy-2'-fluoro-9-î²-d-arabinofuranosylguanine),0,0,0,2,0,2
1 âµg cov2 sam (lnp),0,0,0,2,0,2
10 âµg cov2 sam (lnp),0,0,0,2,0,2
100 mg,0,0,0,2,0,2
18f-î±vî²6-bp,0,0,2,0,0,2
3 âµg cov2 sam (lnp),0,0,0,2,0,2
30 âµg cov2 sam (lnp),0,0,0,2,0,2
300 mg of omega3-fa,0,0,1,1,0,2
99mtc-pertechnetate aerosol,0,0,0,2,0,2
aã§aã­ palm berry extract - natural product,0,0,0,2,0,2
abatacept,0,0,0,2,0,2
acetylsalicylic acid,0,1,0,1,0,2
activase,2,0,0,0,0,2
adsorbed covid-19 (inactivated) vaccine,1,0,1,0,0,2
aeonose,0,2,0,0,0,2
ag0301-covid19,2,0,0,0,0,2
allocetra-ots,1,0,0,1,0,2
"alpha-interferon, abidol, ribavirin, buzhong yiqi plus",2,0,0,0,0,2
ambrisentan,0,0,0,2,0,2
ampion,1,1,0,0,0,2
angiotensin peptide (1-7) derived plasma,0,0,0,2,0,2
antibiotics,0,1,0,1,0,2
apixaban,0,1,0,1,0,2
apremilast,0,0,0,2,0,2
artecomâ® (pyronaridine-artesunate),0,0,0,2,0,2
asbrip,0,2,0,0,0,2
at-527,0,0,0,2,0,2
av-covid-19,1,0,0,1,0,2
avdoralimab,1,0,0,1,0,2
avigan,1,0,0,1,0,2
azd1222,2,0,0,0,0,2
basic feedback,2,0,0,0,0,2
bat,0,0,0,2,0,2
behavioral,0,0,1,0,1,2
bemiparin,0,0,0,2,0,2
bevacizumab,0,1,0,1,0,2
bioargininaâ®,0,0,0,2,0,2
blood draw,0,0,0,2,0,2
brequinar,1,1,0,0,0,2
brii-196,0,0,0,2,0,2
brii-196/brii-198,0,0,0,2,0,2
brii-198,0,0,0,2,0,2
broncho-vaxomâ®,0,0,0,2,0,2
bucillamine,0,0,2,0,0,2
canine odor detection of volatile organic compounds,0,0,0,2,0,2
caring contacts,0,0,1,1,0,2
chest ct,0,1,0,1,0,2
chlorhexidine,0,0,0,2,0,2
citrox,0,2,0,0,0,2
clorhexidine dental phbâ©,0,2,0,0,0,2
conjunctival swab,0,1,0,1,0,2
continuation of arb,0,0,2,0,0,2
"conventional medicines (oxygen therapy, alfa interferon via aerosol inhalation,",0,0,0,2,0,2
"conventional medicines (oxygen therapy, alfa interferon via aerosol inhalation,/lopinavir/ritonavir)/traditional chinese medicines (tcms) granules",0,0,0,2,0,2
conventional oxygen therapy,0,1,0,1,0,2
coronavac,0,0,0,2,0,2
cospherunate,0,0,2,0,0,2
coviage,0,2,0,0,0,2
covid-19 patients,0,0,0,2,0,2
covid-19 symptom monitoring system,0,0,0,2,0,2
covid-viroâ® test,0,2,0,0,0,2
ct-p59,1,0,0,1,0,2
ct-scan,0,1,0,1,0,2
curosurfâ® (poractant alfa),0,0,0,2,0,2
cvncov 12 î¼g,2,0,0,0,0,2
cvncov 12î¼g,2,0,0,0,0,2
cvncov 6 î¼g,2,0,0,0,0,2
cvncov vaccine,1,0,0,1,0,2
cyt107,0,0,0,2,0,2
cytokine adsorption,0,1,0,1,0,2
cytosorb,0,0,0,2,0,2
dapagliflozin,1,0,0,1,0,2
data collection,0,1,0,1,0,2
dipyridamole,0,1,0,1,0,2
discontinuation of arb,0,0,2,0,0,2
discussion board for social support,2,0,0,0,0,2
distilled water,0,1,0,1,0,2
dose),2,0,0,0,0,2
dose) - stage 2,0,0,0,2,0,2
doxycycline tablets,0,0,0,2,0,2
drã¤ger antigen test sars-cov-2,0,0,0,2,0,2
duvelisib,0,0,0,2,0,2
ðžxygen therapy,0,0,0,2,0,2
early-dexamethasone,0,0,0,2,0,2
edp1815,0,0,0,2,0,2
entrã©e: behavioral skills,0,0,0,2,0,2
entrã©e: cognitive skills,0,0,0,2,0,2
entrã©e: interpersonal skills,0,0,0,2,0,2
epivaccorona (epivaccorona vaccine based on peptide antigens for the prevention of covid-19),2,0,0,0,0,2
essential oils,0,1,0,1,0,2
exercise training,0,0,0,2,0,2
exercise/nutrition,0,0,0,2,0,2
exo 1 inhalation,0,1,1,0,0,2
exo 2 inhalation,0,1,1,0,0,2
experimental group,1,1,0,0,0,2
expressive writing,0,2,0,0,0,2
extracorporeal blood purification using the oxirisâ® (an69st) hemofilter,0,0,0,2,0,2
favipiravir/hydroxychloroquine,1,0,0,1,0,2
fit test,0,2,0,0,0,2
folic acid,1,0,0,1,0,2
fuzheng huayu,0,1,0,1,0,2
gammacoreâ® (vagus nerve stimulation),2,0,0,0,0,2
gammacoreâ® sapphire (non-invasive vagus nerve stimulator),0,0,0,2,0,2
gbp510 (rbd 25î¼g,0,0,0,2,0,2
gbp510 adjuvanted with alum (rbd 10î¼g,0,0,0,2,0,2
gbp510 adjuvanted with alum (rbd 25î¼g,0,0,0,2,0,2
gbp510 adjuvanted with as03 (rbd 10î¼g,0,0,0,2,0,2
gbp510 adjuvanted with as03 (rbd 25î¼g,0,0,0,2,0,2
glycine,0,0,0,2,0,2
group hydroxychloroquine,0,2,0,0,0,2
gx-i7,0,0,0,2,0,2
had5-s-fusion/n-etsd vaccine,0,0,0,2,0,2
health supplements,0,0,0,2,0,2
high-dose placebo (18-59 years),0,0,0,2,0,2
high-dose placebo (60-85 years),0,0,0,2,0,2
high-dose recombinant covid-19 vaccine (sf9 cells) (18-59 years),0,0,0,2,0,2
high-dose recombinant covid-19 vaccine (sf9 cells) (60-85 years),0,0,0,2,0,2
high dosage inactivated sars-cov-2 vaccine,2,0,0,0,0,2
high flow nasal cannula,0,1,0,1,0,2
high flow nasal cannula (hfnc),0,0,0,2,0,2
hormones,1,0,0,1,0,2
human amniotic fluid,0,0,0,2,0,2
hydroxychloroquine/clindamycin/primaquine,0,2,0,0,0,2
hzvsf-v13,0,0,0,2,0,2
ibrutinib,0,0,0,2,0,2
ibuprofen,0,0,0,2,0,2
id nowâ„¢ covid-19 screening test,2,0,0,0,0,2
igg,0,1,0,1,0,2
igm antibodytest,0,1,0,1,0,2
igm/igg rapid test,0,1,0,1,0,2
iloprost,1,0,0,1,0,2
imatinib,0,0,0,2,0,2
imu-838,0,0,0,2,0,2
infliximab,0,1,0,1,0,2
interferon-ãÿ-1a,0,0,0,2,0,2
interferon-î² 1a,0,0,2,0,0,2
interferon î²-1b,0,0,0,2,0,2
interleukin,0,0,0,2,0,2
intramuscular vaccine,1,0,0,1,0,2
iota-carrageenan,0,1,0,1,0,2
kb109,1,0,0,1,0,2
kb109 / self supportive care (ssc),1,0,0,1,0,2
l-citrulline,0,0,0,2,0,2
lanadelumab,0,0,0,2,0,2
laryngoscopy,0,2,0,0,0,2
ledipasvir,0,2,0,0,0,2
leflunomide,0,0,0,2,0,2
life2000â® ventilator,0,0,0,2,0,2
lopinavir/ ritonavir,0,0,0,2,0,2
low-dose placebo (18-59 years),0,0,0,2,0,2
low-dose placebo (60-85 years),0,0,0,2,0,2
low-dose recombinant covid-19 vaccine (sf9 cells) (18-59 years),0,0,0,2,0,2
low-dose recombinant covid-19 vaccine (sf9 cells) (60-85 years),0,0,0,2,0,2
lucira covid-19 all-in-one test kit,0,1,0,1,0,2
lung ultrasound,0,0,0,2,0,2
m5049,0,0,0,2,0,2
"magpro x100 stimulator, b70 fluid-cooled coil",0,0,0,2,0,2
maraviroc,0,1,0,1,0,2
marker therapeutics d2000 cartridge (d2000) for use with the spectra optiaâ® apheresis system (optia spd protocol),0,0,0,2,0,2
mask,0,2,0,0,0,2
meditation,0,0,1,1,0,2
meditation (1 x 20-minute guided audio training),0,0,0,2,0,2
medium dosage inactivated sars-cov-2 vaccine,2,0,0,0,0,2
medium dosage inactivated sars-cov-2 vaccine on a 0-/28-day schedule,0,0,1,1,0,2
mefloquine,0,2,0,0,0,2
metanebâ® system,0,0,0,2,0,2
"minus formula, huhuang detoxicity paste, baimu qingre jiedu paste",2,0,0,0,0,2
moderna covid-19 vaccine,0,0,0,2,0,2
molnupiravir,0,0,0,2,0,2
motivational interviewing,0,0,0,2,0,2
n-acetyl cysteine,1,0,0,1,0,2
n-etsd vaccine,0,0,0,2,0,2
nasopharyngeal swabs,0,0,0,2,0,2
neuromuscular electrical stimulation,0,0,0,2,0,2
nigella sativa,0,1,0,1,0,2
nioâ® (intraosseous access),0,2,0,0,0,2
nitric oxide delivered via lungfitâ„¢ system,0,0,0,2,0,2
no intervention,0,2,0,0,0,2
normal saline (0.9% sodium chloride solution)- stage 2,0,0,0,2,0,2
nusepinâ® 0.1 mg,0,0,0,2,0,2
nusepinâ® 0.2 mg,0,0,0,2,0,2
ocat,0,0,0,2,0,2
octagam,1,1,0,0,0,2
omegavenâ®,0,0,0,2,0,2
online support group,1,1,0,0,0,2
opaganib,0,1,0,1,0,2
ophthalmologic exam,0,1,0,1,0,2
oral polio vaccine,0,0,2,0,0,2
osoc,0,0,0,0,2,2
oximenâ® 3%,0,2,0,0,0,2
oxygen-ozone,0,0,0,2,0,2
pegylated interferon-î±2b,0,0,0,2,0,2
performance evaluation,0,0,0,2,0,2
personalized feedback,2,0,0,0,0,2
phase 1,0,0,0,2,0,2
physical therapy,1,0,0,1,0,2
placebo (normal saline solution),0,0,0,2,0,2
plx-pad,0,0,0,2,0,2
prayer,0,0,0,2,0,2
preventive information,2,0,0,0,0,2
proxalutamide,1,1,0,0,0,2
pul-042,0,0,0,2,0,2
pulmonary rehabilitation,0,0,1,1,0,2
pyronaridine-artesunate,0,0,0,2,0,2
qazcovid-inâ®-vaccine against covid-19,2,0,0,0,0,2
qazcovid-inâ® - covid-19 inactivated vaccine,0,2,0,0,0,2
quality-of-life assessment,0,0,0,2,0,2
rapid diagnostic test vs pcr,0,0,0,2,0,2
recombinant human interferon î±2b spray,2,0,0,0,0,2
recombinant new coronavirus vaccine (cho cell) low-dose group,2,0,0,0,0,2
recombinant new coronavirus vaccine (cho cells) high-dose group,2,0,0,0,0,2
regn10933 / regn10987,1,0,0,1,0,2
resveratrol,2,0,0,0,0,2
rhea health toneâ®,0,0,0,2,0,2
ribaroxaban,0,0,0,2,0,2
rivaroxaban 10 mg,0,0,0,2,0,2
roactemra,0,0,0,0,2,2
rosuvastatin,0,0,0,2,0,2
rtb101,1,0,0,0,1,2
ruconest,0,0,0,2,0,2
saline containing 1% human serum albuminï¼ˆsolution without uc-mscsï¼‰,0,2,0,0,0,2
sample collection,0,0,0,2,0,2
self supportive care (ssc),1,0,0,1,0,2
self supportive care (ssc) alone,1,0,0,1,0,2
selinexor,0,1,0,1,0,2
serum test,0,1,0,1,0,2
silmitasertib,0,0,0,2,0,2
siltuximab,1,0,0,1,0,2
silymarin,0,0,0,2,0,2
simple cognitive task intervention,0,0,0,2,0,2
sirolimus,0,0,0,2,0,2
smf,0,2,0,0,0,2
soc / placebo,0,1,0,1,0,2
sodium bicarbonate,1,0,0,1,0,2
sofosbuvir/daclatasvir,0,0,0,2,0,2
sofosbuvir/ledipasvir,0,2,0,0,0,2
splenic ultrasound,0,0,1,1,0,2
standard covid-19 care,0,0,0,2,0,2
stp,0,0,0,2,0,2
surgical mask,0,1,0,1,0,2
tacrolimus,0,0,0,2,0,2
td-0903,0,1,0,1,0,2
tele-yoga,0,2,0,0,0,2
tenofovir disoproxil,0,0,0,2,0,2
testing,0,0,0,2,0,2
"three doses of placebo at the schedule of day 0, 14, 28ï¼ˆhigh-dose groupï¼‰",2,0,0,0,0,2
thromboprophylaxis,0,0,0,2,0,2
thymalfasin,0,0,0,2,0,2
tricorâ® 145mg tablets,0,0,0,2,0,2
two dose chadox1 ncov-19,0,0,0,2,0,2
"two doses of low dosage inactivated sars-cov-2 vaccine at the schedule of day 0,28",1,0,0,1,0,2
"two doses of medium dosage inactivated sars-cov-2 vaccine at the schedule of day 0,28",1,0,0,1,0,2
"two doses of placebo at the schedule of day 0, 28ï¼ˆhigh-dose groupï¼‰",2,0,0,0,0,2
"two doses of placebo at the schedule of day 0, 28ï¼ˆmiddle-dose groupï¼‰",2,0,0,0,0,2
ub-612,0,0,0,2,0,2
uvc irradiation,0,2,0,0,0,2
vehicle control,0,0,0,2,0,2
video chat,2,0,0,0,0,2
virazole,0,0,0,2,0,2
vitis xtra forteâ©,0,2,0,0,0,2
viusid,0,2,0,0,0,2
volatile organic compounds analysis,0,0,0,2,0,2
vv-ecmo,0,2,0,0,0,2
water,0,1,0,0,1,2
yoga,0,0,0,2,0,2
zilucoplanâ®,2,0,0,0,0,2
-interferon nebulization,0,1,0,0,0,1
"""calm"" is a mindfulness meditation mobile app",0,1,0,0,0,1
"""sham""-block with placebo (isotone nacl)",0,0,0,1,0,1
),0,0,1,0,0,1
0.07% cetylpyridinium chloride (cpc) in mouthwash,0,0,0,1,0,1
0.075% cetylpyridinium chloride,0,0,0,1,0,1
0.075% cetylpyridinium chloride (cpc),0,0,0,1,0,1
0.1% sodium hypochlorite,0,0,0,1,0,1
0.12% chg oral rinse,0,0,0,1,0,1
0.12% chlorhexidine gluconate,0,0,0,1,0,1
0.12% chlorhexidine gluconate mouth rinse,0,0,0,1,0,1
0.4ml inj syringe 0.4ml,0,0,0,1,0,1
0.5% povidone iodine,0,0,0,1,0,1
0.5ml,0,0,0,1,0,1
0.9% (w,1,0,0,0,0,1
0.9% (w/v) saline,1,0,0,0,0,1
0.9% normal saline,0,0,0,1,0,1
1% hydrogen peroxide,0,0,0,1,0,1
1% povidone iodine (pvp-i),0,0,0,1,0,1
1% w,0,0,0,1,0,1
1% w/v povidone-iodide,0,0,0,1,0,1
1.5-2% w,0,0,0,1,0,1
1.5-2% w/v hydrogen peroxide,0,0,0,1,0,1
1.5% hydrogen peroxide (h2o2),0,0,0,1,0,1
10 to 14 days later,0,0,0,1,0,1
100 mg/ml virazole,0,0,0,1,0,1
"12.7% fio2, hypercapnia 7% co2, inspiratory mechanical constraint",0,0,0,1,0,1
15mg,0,0,0,1,0,1
1600 mg),1,0,0,0,0,1
2.2x10^10vp (qpcr) boost,0,0,0,1,0,1
21 - phase 2,1,0,0,0,0,1
21% ethanol,0,0,0,1,0,1
21% ethanol/essential oils,0,0,0,1,0,1
24 hour holter ecg,0,0,0,1,0,1
24h transdermal patch - 24 hour,0,0,0,1,0,1
28),0,0,0,1,0,1
2nd dose),0,0,0,1,0,1
3),0,0,0,0,1,1
400 mg,0,0,0,1,0,1
4plants,0,0,1,0,0,1
4plants/azythromycin,0,0,1,0,0,1
5-ala-phosphate,0,0,0,1,0,1
5-ala-phosphate / sfc (5-ala / sfc),0,0,0,1,0,1
5% glucose,1,0,0,0,0,1
50 mg,0,0,0,1,0,1
50 mg/ml virazole,0,0,0,1,0,1
6 minutes walk test,0,0,0,1,0,1
6 months later,0,0,0,1,0,1
600mg) oral suspension,0,0,0,1,0,1
99mtc-pertechnetate,0,0,0,1,0,1
a $10 survey incentive,1,0,0,0,0,1
a $20 survey incentive,1,0,0,0,0,1
"a high-dose placebo (18-59 years) at the schedule of day 0, 28, 56",0,0,0,1,0,1
"a high-dose placebo (60-85 years) at the schedule of day 0, 28, 56",0,0,0,1,0,1
"a high-dose recombinant covid-19 vaccine (cho cell) (18-59 years) at the schedule of day 0, 28, 56",0,0,0,1,0,1
"a high-dose recombinant covid-19 vaccine (cho cell) (60-85 years) at the schedule of day 0, 28, 56",0,0,0,1,0,1
"a middle-dose placebo (18-59 years) at the schedule of day 0, 28, 56",0,0,0,1,0,1
"a middle-dose placebo (60-85 years) at the schedule of day 0, 28, 56",0,0,0,1,0,1
"a middle-dose recombinant covid-19 vaccine (cho cell) (18-59 years) at the schedule of day 0, 28, 56",0,0,0,1,0,1
"a middle-dose recombinant covid-19 vaccine (cho cell) (60-85 years) at the schedule of day 0, 28, 56",0,0,0,1,0,1
a short video intervention,0,0,0,1,0,1
a vignette intervention,0,0,0,1,0,1
aapc,0,0,0,1,0,1
aaz covid-19 rapid test,0,1,0,0,0,1
abbc1 immunoessential,0,0,0,1,0,1
abbv-2b04,0,0,0,1,0,1
abbv-47d11,0,0,0,1,0,1
abivertinib,0,0,0,1,0,1
abx464,0,0,0,1,0,1
accuchek inform ii platform,0,1,0,0,0,1
"ace inhibitor, angiotensin receptor blocker",0,1,0,0,0,1
acknowledgement racial injustice ama,1,0,0,0,0,1
actigraphy,0,0,0,1,0,1
action (tara),0,1,0,0,0,1
active comparator,0,0,0,1,0,1
active control:healthy living,0,1,0,0,0,1
activity list,1,0,0,0,0,1
ad5-ncov,1,0,0,0,0,1
adcld-cov19,0,0,0,1,0,1
adcovid,0,0,0,1,0,1
adenovirus type-5 vectored covid-19 vaccine,1,0,0,0,0,1
adg20,0,0,0,1,0,1
adimrsc-2f,0,0,0,1,0,1
adm03820,0,0,0,1,0,1
administration of equine immunoglobulin anti sars-cov-2,0,1,0,0,0,1
adsorbed sars-cov-2 (inactivated) vaccine,0,0,0,1,0,1
aerobic exercises,0,0,1,0,0,1
aerobic training,0,0,0,1,0,1
aerosolized dnase,0,0,0,1,0,1
african american sender acknowledgement,1,0,0,0,0,1
african american sender in informational videos.,1,0,0,0,0,1
after-each-case room disinfection,0,1,0,0,0,1
agent-797,0,0,0,1,0,1
ai algorithm,0,0,0,1,0,1
ak119,0,0,0,1,0,1
alanine,0,0,0,1,0,1
albumine,0,1,0,0,0,1
alcohol mouthwash (listerine) (d) mouth rinse with the solution provided,0,0,0,1,0,1
aldesleukin,0,0,0,1,0,1
allogeneic,1,0,0,0,0,1
allogeneic mesenchymal stem cell,0,1,0,0,0,1
almitrine,0,0,0,1,0,1
"alpha-interferon alpha, abidol, ribavirin, buzhong yiqi plus",1,0,0,0,0,1
"alpha-interferon alpha, abidol, ribavirin, buzhong yiqi plus/minus formula, huhuang detoxicity paste, baimu qingre jiedu paste, fumigation/inhalation of vitamin c",1,0,0,0,0,1
"alpha-interferon, abidol, ribavirin, buzhong yiqi plus/minus formula, huhuang detoxicity paste, baimu qingre jiedu paste/5% glucose",1,0,0,0,0,1
"alpha-interferon, abidol, ribavirin, buzhong yiqi plus/minus formula, huhuang detoxicity paste, baimu qingre jiedu paste/high-dose vitamin c treatment",1,0,0,0,0,1
alpha one antitrypsin,0,0,0,1,0,1
alteplase,0,0,0,1,0,1
alum adjuvant,1,0,0,0,0,1
aluminum adjuvant of inactivated sars-cov-2 vaccine,1,0,0,0,0,1
alvelestat,0,0,0,1,0,1
alveolar,0,0,0,1,0,1
ama acknowledgement drug pricing,1,0,0,0,0,1
ambulation,0,0,0,1,0,1
amiodarone,0,0,0,1,0,1
amlodipine,0,0,0,1,0,1
an69-oxiris,0,0,0,1,0,1
an69-standard,0,0,0,1,0,1
anakinra/osoc,0,0,0,0,1,1
anakinra/ruxolitinib,0,0,0,0,1,1
ang-3777,0,0,0,1,0,1
anger message,0,1,0,0,0,1
angiography scanner,0,0,0,1,0,1
angiotensin,0,0,0,1,0,1
angiotensin-(1-7),0,0,0,1,0,1
angiotensin ii receptor blockers,0,0,0,1,0,1
anise,0,0,0,1,0,1
anluohuaxian,0,0,0,1,0,1
anti-cd14,0,0,0,1,0,1
anti-coronavirus antibodies (immunoglobulins)obtained with dfpp from convalescent patients,0,0,0,1,0,1
anti-sars-cov-2 igt seropositivity,0,1,0,0,0,1
anti-sars-cov-2 igy,0,1,0,0,0,1
antibody test,0,1,0,0,0,1
anticoagulation agents (edoxaban and,0,0,0,1,0,1
anticoagulation agents (edoxaban and/or high dose lmwh),0,0,0,1,0,1
antihypertensives,0,0,0,1,0,1
antioxidants,0,0,0,1,0,1
antithrombin,0,1,0,0,0,1
antithrombin / best available treatment,0,1,0,0,0,1
antroquinonol,0,0,0,1,0,1
anxiety,0,0,0,1,0,1
apilimod dimesylate,0,0,0,1,0,1
apixaban 5mg,0,0,0,1,0,1
apl-9,0,0,0,1,0,1
apps,0,0,0,1,0,1
apremilast placebo,0,0,0,1,0,1
aprepitant injectable emulsion,0,0,0,1,0,1
aprotinin,1,0,0,0,0,1
arbidol hydrochloride/interferon atomization,0,0,0,1,0,1
arbox,0,0,0,0,1,1
arct-021 dose 1,0,0,0,1,0,1
arct-021 dose 2,0,0,0,1,0,1
arct-021 dose 3,0,0,0,1,0,1
arct-021 dose 4,0,0,0,1,0,1
arct-021 dose regimen 1,0,0,0,1,0,1
arct-021 dose regimen 2,0,0,0,1,0,1
arct-021 single dose priming,1,0,0,0,0,1
arct-021 two higher dose priming,1,0,0,0,0,1
arct-021 two lower dose priming,1,0,0,0,0,1
ardsnet,0,0,0,1,0,1
argatroban,0,0,0,1,0,1
artemesia annua,0,0,0,1,0,1
artemether-lumefantrine (al),0,0,0,1,0,1
artemic,0,1,0,0,0,1
artemisia annua leaf,0,0,0,1,0,1
artesunate,0,0,0,1,0,1
artesunate-amodiaquine,0,0,0,1,0,1
asc09,0,0,0,1,0,1
asc09f/oseltamivir,0,0,0,1,0,1
ascorbic acid/zinc gluconate,0,1,0,0,0,1
ashmolean website,0,0,0,1,0,1
asp,0,0,0,1,0,1
aspirin 25mg orally,0,0,0,1,0,1
assembled mask,1,0,0,0,0,1
"assessing antibody responses, neutralizing capacity",1,0,0,0,0,1
"assessing antibody responses, neutralizing capacity/memory b-cell function",1,0,0,0,0,1
assigned strategies: active choice,0,0,0,1,0,1
assigned strategies: enhanced active choice,0,0,0,1,0,1
assigned strategies: opt-in,0,0,0,1,0,1
asunercept,0,0,0,1,0,1
asunercept 100mg,0,0,0,1,0,1
asunercept 25mg,0,0,0,1,0,1
asunercept 400mg,0,0,0,1,0,1
at-001,0,1,0,0,0,1
atazanavir/dexamethasone,0,0,0,1,0,1
ati-450,0,0,0,1,0,1
atorvastatin / l-arginine / folic acid / nicorandil / nebivolol,0,0,0,1,0,1
atorvastatin 20 mg oral tablet,0,0,0,1,0,1
atovaquone,0,0,0,1,0,1
atovaquone/azithromycin,0,0,0,1,0,1
atr-002,0,0,0,1,0,1
attention bias modification (abm),0,1,0,0,0,1
audio for relaxation techniques,0,0,0,1,0,1
auditory evoked potentials (aep),0,0,0,1,0,1
augmented message,0,0,0,1,0,1
auricular neuromodulation,0,0,0,1,0,1
auricular percutaneous neurostimulation,0,0,0,1,0,1
auricular stimulation,0,0,0,1,0,1
autologous activated platelet-rich plasma,0,0,0,1,0,1
autologous non-hematopoietic peripheral blood stem cells (nhpbsc),0,1,0,0,0,1
autophagy inhibitor (gns651),0,0,0,1,0,1
auxora,0,0,0,1,0,1
aviptadil,0,1,0,0,0,1
aviptadil/standard care,0,1,0,0,0,1
award,0,0,0,1,0,1
award advice,0,0,0,1,0,1
award/covid-specific advice,0,0,0,1,0,1
azd1656,0,0,0,1,0,1
azd7442 (im),0,0,0,1,0,1
azd7442 (iv),0,0,0,1,0,1
azithromycin / ivermectin / ribaroxaban / paracetamol,0,0,0,1,0,1
azithromycin / ribaroxaban / paracetamol,0,0,0,1,0,1
azoximer bromide,1,0,0,0,0,1
b: placebo,0,0,0,1,0,1
bactek-r,0,0,0,1,0,1
bactrl-spike,1,0,0,0,0,1
bandebereho fathers',0,0,1,0,0,1
bardoxolone methyl,0,1,0,0,0,1
baseline,0,0,0,1,0,1
baseline blood sample,0,0,0,1,0,1
baseline message,0,1,0,0,0,1
baseline/during hospitalization blood samples,0,0,0,1,0,1
bat / calcifediol,0,0,0,1,0,1
bbv152,1,0,0,0,0,1
bbv152a - phase i,1,0,0,0,0,1
bbv152a - phase ii,1,0,0,0,0,1
bbv152b - phase i,1,0,0,0,0,1
bbv152b - phase ii,1,0,0,0,0,1
bbv152c - phase i,1,0,0,0,0,1
bbv154 vaccine,1,0,0,0,0,1
bcg-10 vaccine,0,0,0,1,0,1
bdb-001 injection,0,0,0,1,0,1
behavioral activation ssi,1,0,0,0,0,1
behavioral economics,0,0,0,1,0,1
behaviour change technique intervention to improve quality of life,0,0,0,1,0,1
bemiparin sodium,0,0,0,1,0,1
bempegaldesleukin,0,0,0,1,0,1
berberine,0,1,0,0,0,1
bereavement virtual support group,0,0,1,0,0,1
best message,0,0,0,1,0,1
best message / augmented message/implementation strategy,0,0,0,1,0,1
best message alone,0,0,0,1,0,1
best symptomatic treatment based on doctor recommendations),0,0,0,1,0,1
betadine (c) mouth rinse with the solution provided,0,0,0,1,0,1
betadineâ© bucal 100 mg,0,1,0,0,0,1
betadineâ© bucal 100 mg/ml,0,1,0,0,0,1
bgb-dxp593,0,1,0,0,0,1
bgb dxp593,0,0,0,1,0,1
bge-175,0,0,0,1,0,1
bi 764198,0,0,0,1,0,1
bicalutamide 150 mg,0,0,0,1,0,1
bicalutamide 150 mg oral tablet,0,0,0,1,0,1
bidirectional oxygenation mouthpiece,0,0,0,1,0,1
bio 300 oral suspension,0,0,0,1,0,1
bio101,0,0,0,1,0,1
biobehavioral tele-rehabilitation sessions,0,0,0,1,0,1
biocollection,0,0,0,1,0,1
biological test,0,0,0,1,0,1
biological/vaccine: recombinant new coronavirus vaccine (cho cell) low-dose group,1,0,0,0,0,1
biological/vaccine: recombinant new coronavirus vaccine (cho cells) high-dose group,1,0,0,0,0,1
biological/vaccine: recombinant new coronavirus vaccine (cho cells) placebo group,1,0,0,0,0,1
biological: mrna-1273,1,0,0,0,0,1
biosensor,0,0,0,1,0,1
biospecimen collection,0,0,0,1,0,1
biovitals,0,0,0,1,0,1
biozek covid-19 antigen rapid test,0,0,0,1,0,1
bivalirudin,0,0,0,1,0,1
bld-2660,1,0,0,0,0,1
blink,0,0,0,1,0,1
blink/masseter inhibitory reflex,0,0,0,1,0,1
blood collection on their first consultation/10 to 14 days later,0,0,0,1,0,1
blood group determination,0,0,0,1,0,1
blood sample analyses,0,0,0,1,0,1
blood sample/data record,0,0,0,1,0,1
blood/derivatives,0,0,0,1,0,1
bms-986253,0,0,0,1,0,1
bno 1030,0,1,0,0,0,1
bnt162a1,0,0,0,1,0,1
bnt162b3,1,0,0,0,0,1
bnt162c2,0,0,0,1,0,1
body position change,0,0,0,1,0,1
boost,0,0,0,1,0,1
botulinum neurotoxin,0,1,0,0,0,1
bovine plasma-derived immunoglobulin concentrate,0,0,0,1,0,1
brain mri,0,0,0,1,0,1
brain parenchyma biopsies,0,0,0,1,0,1
brazilian green propolis extract (epp-af),0,1,0,0,0,1
breath biopsy,0,0,0,1,0,1
breath test,0,1,0,0,0,1
breath test/cheek swab,0,1,0,0,0,1
"breathing exercise, intensive spirometry use, supported cough, progressive mobilisation",0,0,0,1,0,1
"breathing exercise, intensive spirometry use, supported cough, progressive mobilisation/ambulation",0,0,0,1,0,1
brensocatib,0,1,0,0,0,1
brexanolone,0,0,0,1,0,1
bridge therapy,0,0,0,1,0,1
brief counseling,0,0,0,1,0,1
brief informational infographic,0,1,0,0,0,1
brief interpersonal telepsychotherapy,0,0,1,0,0,1
brief mindfulness based intervention,0,1,0,0,0,1
brief skills for safer living,0,0,0,1,0,1
brilacidin,0,0,0,1,0,1
broad-spectrum cbd oil,0,0,0,1,0,1
bromelain,0,0,0,1,0,1
bromhexine 8 mg placebo,0,0,1,0,0,1
bromhexine oral tablet and/or hydroxychloroquine tablet,0,0,0,1,0,1
btl-tml-covid,0,0,0,1,0,1
butterfly iq,0,0,0,1,0,1
c-135-ls,1,0,0,0,0,1
c144-ls,1,0,0,0,0,1
c144-ls/c-135-ls,1,0,0,0,0,1
c21,0,1,0,0,0,1
calcifediol,0,0,0,1,0,1
camostat mesylate,0,0,0,1,0,1
candesartan,0,0,0,1,0,1
canswab,0,0,0,1,0,1
cap-1002,0,0,0,1,0,1
capillary collection,0,0,0,1,0,1
capillary collection/testing,0,0,0,1,0,1
care as usual,0,0,1,0,0,1
caring contacts without an introductory phone call (cc),0,0,1,0,0,1
caring contacts/introductory phone call (cc/),0,0,1,0,0,1
carragelose,0,0,0,1,0,1
cash transfer,1,0,0,0,0,1
castem,0,0,0,1,0,1
cbd isolate,0,0,0,1,0,1
ccp,0,0,0,1,0,1
cd24fc,0,1,0,0,0,1
cefditoren pivoxil 400mg,0,0,0,1,0,1
cell therapy protocol 1,0,0,0,1,0,1
cell therapy protocol 2,0,0,0,1,0,1
centricyte 1000,0,0,0,1,0,1
cerc-002,0,1,0,0,0,1
"cerebrospinal fluid sampling, meningeal",0,0,0,1,0,1
"cerebrospinal fluid sampling, meningeal/brain parenchyma biopsies",0,0,0,1,0,1
certified cloth face mask,1,0,0,0,0,1
certified cloth face mask/preventive information,1,0,0,0,0,1
chadox1 ncov-19 0.5ml (3.5-6.5x10^10vp) late vaccine (lv),1,0,0,0,0,1
chadox1 ncov-19 0.5ml (3.5-6.5x10^10vp) late vaccine two (lvt),1,0,0,0,0,1
chadox1 ncov-19 single dose,0,0,0,1,0,1
chadox1 ncov-19 single dose / paracetamol,0,0,0,1,0,1
chadox1 ncov-19 two dose,0,0,0,1,0,1
chadox1 ncov-19 two dose / paracetamol,0,0,0,1,0,1
chadv68-s,0,0,0,1,0,1
chadv68-s-tce,0,0,0,1,0,1
"change in knowledge, motivation, skills, resources",0,0,0,1,0,1
chat-based instant messaging support,0,1,0,0,0,1
chat-based support,0,0,0,1,0,1
check-list including lung ultrasound,0,0,0,1,0,1
cheek swab,0,1,0,0,0,1
chemokines profiles of patients with dexmedetomidine administration,0,0,0,1,0,1
chest physiotherapy post-covid19,0,0,0,1,0,1
chest x-ray,0,0,0,1,0,1
chiropractic care (more than one visit),0,1,0,0,0,1
chiropractic care (one visit),0,1,0,0,0,1
chlorhexidine gluconate (a) mouth rinse with the solution provided,0,0,0,1,0,1
chlorine dioxide,0,0,0,1,0,1
choice of assignment: active choice,0,0,0,1,0,1
choice of assignment: enhanced active choice,0,0,0,1,0,1
choice of assignment: opt-in,0,0,0,1,0,1
chx0.12,0,1,0,0,0,1
chx0.12/cpc0.05 oral rinse (perioaidactive control),0,1,0,0,0,1
cig axial,0,1,0,0,0,1
cig tilted,0,1,0,0,0,1
ck0802,0,0,0,1,0,1
clarithromycin,0,1,0,0,0,1
clarithromycin 500mg,0,1,0,0,0,1
clevudine,0,0,0,1,0,1
clinical decision support system based on non-invasive multimodal monitoring,1,0,0,0,0,1
clinical examination,1,0,0,0,0,1
cliniporator,1,0,0,0,0,1
cliniporatorâ®,0,0,0,1,0,1
cliniporatorâ®/epsgun,0,0,0,1,0,1
clofazimine,0,0,0,1,0,1
closed face shield with surgical face mask use,1,0,0,0,0,1
cm4620-ie (injectable emulsion),0,0,0,1,0,1
co-mestring (co-coping),0,0,0,1,0,1
cobicistat,0,0,0,1,0,1
cod liver oil,0,0,0,1,0,1
cognitive,0,0,0,1,0,1
cognitive activity,0,0,0,1,0,1
"cognitive behavior therapy (cbt), specifically using the facing your fears (fyf) curriculum",0,0,0,1,0,1
cognitive behavioral brief-telepsychotherapy,0,0,1,0,0,1
cognitive behavioural group therapy for perinatal anxiety,0,0,0,1,0,1
colchicine 0.5 mg,0,0,0,1,0,1
colchicine 0.6 mg,0,0,1,0,0,1
colchicine pill,0,0,0,1,0,1
colchicine/herbal phenolic monoterpene fractions,0,0,0,1,0,1
colchicine/symptomatic treatment (paracetamol),0,0,0,1,0,1
colgate periogard mouthwash,0,0,1,0,0,1
colgate peroxyl mouthwash,0,0,1,0,0,1
colgate total mouthwash,0,0,1,0,0,1
collagen-polyvinylpyrrolidone,0,0,0,1,0,1
"collection of blood, salivary",0,0,0,1,0,1
"collection of blood, salivary/nasopharyngeal samples.",0,0,0,1,0,1
combination,0,1,0,0,0,1
combined art,0,0,0,1,0,1
combined art/hydroxychloroquine,0,0,0,1,0,1
comirnaty - biontech manufacturing gmbh,0,0,0,1,0,1
"comirnaty (covid-19, mrna vaccine)",0,0,0,1,0,1
communication type,0,1,0,0,0,1
"community-based, mobile van testing",0,0,1,0,0,1
community health worker support,0,0,1,0,0,1
community health workers.,1,0,0,0,0,1
community interest message,0,1,0,0,0,1
community mask,0,0,0,1,0,1
comparison group,1,0,0,0,0,1
compass,0,0,0,1,0,1
compassion exercises,0,0,0,1,0,1
compassion focused intervention,0,1,0,0,0,1
complement dosage,0,0,0,1,0,1
conestat alfa,0,0,0,1,0,1
conjunctival swab/nasopharyngeal swab,0,0,0,1,0,1
contain covid anxiety ssi,0,1,0,0,0,1
continuation of acei,0,0,0,1,0,1
continuation of acei/arb,0,0,0,1,0,1
continuation of ras blocker,0,0,0,1,0,1
continued self-enhancement (enhance) for covid-19,0,0,1,0,0,1
continuous blind glucose measurement device (free style pro),0,0,0,1,0,1
continuous glucose monitor (cgm),0,0,0,1,0,1
continuous positive airway pressure,0,0,0,1,0,1
continuous vital sign monitoring - isansys patient status engine,0,0,0,1,0,1
contrast-enhanced cmr,0,0,0,1,0,1
control blend,0,0,0,1,0,1
control group - waiting list,0,0,0,1,0,1
control group (standard hospital treatment),0,1,0,0,0,1
control message,0,1,0,0,0,1
control patients,0,0,0,1,0,1
control swab,0,0,0,1,0,1
control test,0,0,0,1,0,1
controls,0,0,0,1,0,1
convalescent plasma infusion,0,0,0,1,0,1
convalescent plasma with antibody against sars-cov-2.,0,0,0,1,0,1
convalescent plasma/standard care,0,0,0,1,0,1
convalscent plasma,0,0,0,1,0,1
"conventional medicines (oxygen therapy, alfa interferon via aerosol inhalation,/lopinavir/ritonavir)",0,0,0,1,0,1
conventional n95 respirator,0,0,0,1,0,1
conventional therapy first,1,0,0,0,0,1
convp,0,0,0,1,0,1
core warming,0,0,0,1,0,1
corn oil (placebo),0,0,0,1,0,1
corvax,1,0,0,0,0,1
cosh self-help smoking cessation booklet,0,0,0,1,0,1
cospherunate/azythromycine,0,0,1,0,0,1
cospherunate/phytomedicine/azythromycien,0,0,1,0,0,1
cost-benefit frame,1,0,0,0,0,1
counselling,1,0,0,0,0,1
"couple hopes guided, internet-delivered, self-help intervention",0,0,0,1,0,1
couples' group education,0,0,1,0,0,1
covi-vac,0,0,0,1,0,1
covid-19 antigen,0,0,0,1,0,1
"covid-19 antigen/antibody rapid testing, mobile device image capture/telemedicine support",0,0,0,1,0,1
covid-19 barrier box,0,1,0,0,0,1
covid-19 convalescent plasma (cp),0,0,0,1,0,1
covid-19 diagnostic test,0,1,0,0,0,1
covid-19 related health warning leaflet,0,0,0,1,0,1
covid-19 swab,0,0,0,1,0,1
covid-19 vaccine astrazeneca suspension for injection,0,0,0,1,0,1
covid-19 vaccine moderna dispersion for injection - moderna biotech,0,0,0,1,0,1
covid-evax,0,0,0,1,0,1
covid-higiv,0,0,0,1,0,1
covid-specific advice,0,0,0,1,0,1
covid 19 self-questionnaire,0,0,0,1,0,1
covid 19 serology,0,0,0,1,0,1
covid watch,1,0,0,0,0,1
covid19 vaccine,0,0,0,1,0,1
covishield,0,0,0,1,0,1
covishield 0.25ml,0,0,0,1,0,1
covishield 0.5ml,0,0,0,1,0,1
coviv,0,0,0,1,0,1
coviv only (1st,0,0,0,1,0,1
coviv only (1st/2nd dose),0,0,0,1,0,1
coviv/iiv4; coviv/ppv23,0,0,0,1,0,1
covsurf drug delivery system,0,0,0,1,0,1
cpc0.05 oral rinse (perioaidactive control),0,1,0,0,0,1
cpi-006,0,0,0,1,0,1
cpi-006 1 mg,0,0,0,1,0,1
cpi-006 1 mg/kg / soc,0,0,0,1,0,1
cpi-006 2 mg,0,0,0,1,0,1
cpi-006 2 mg/kg / soc,0,0,0,1,0,1
cretan iama,0,1,0,0,0,1
cri management,0,0,1,0,0,1
crisis intervention therapy,0,0,1,0,0,1
critical dialogue,0,0,0,1,0,1
crizanlizumab,0,1,0,0,0,1
cryo lung biopsies,0,0,1,0,0,1
csl760,0,0,0,1,0,1
cst-2: eidd-2801,0,0,0,1,0,1
cst-2: placebo,0,0,0,1,0,1
csvf,0,0,0,1,0,1
ct-p59/placebo,0,0,0,1,0,1
ctus examination,0,0,0,1,0,1
cuff application with inflation,0,0,0,1,0,1
cumin,0,1,0,0,0,1
cupping,0,0,0,1,0,1
current care per ucla treating physicians,0,0,0,1,0,1
current ipac-uhn ppe,0,0,0,1,0,1
cvncov,0,0,0,1,0,1
cyp-001,0,0,0,1,0,1
cytokines,0,0,0,1,0,1
d,1,0,0,0,0,1
d followed by enoxaparin,1,0,0,0,0,1
daclatasvir 200mg,0,0,0,1,0,1
daily coping toolkit,0,0,0,1,0,1
daily monitoring,0,0,0,1,0,1
daily room disinfection,0,1,0,0,0,1
dalcetrapib,0,0,0,1,0,1
dalteparin,0,0,0,1,0,1
danoprevir,0,1,0,0,0,1
danoprevir/ritonavir,0,1,0,0,0,1
dapansutrile capsules,0,0,0,1,0,1
darunavir,0,0,0,1,0,1
darunavir/cobicistat,0,0,0,1,0,1
das181,0,1,0,0,0,1
data collection/rhinopharyngeal swab,0,1,0,0,0,1
data record,0,0,0,1,0,1
ddpcr,0,0,0,1,0,1
decision science-based design,0,0,0,1,0,1
decision tool for clinicians,0,0,0,1,0,1
decitabine,0,0,0,1,0,1
dect,0,0,1,0,0,1
deep breathing training,0,1,0,0,0,1
deferoxamine,0,0,0,1,0,1
defibrotide 25 mg/kg 24 hours continuous infusion for 15 days,0,0,0,1,0,1
degarelix,0,0,0,1,0,1
deglycyrrhizinated licorice,0,0,0,1,0,1
derivatives.,0,0,0,1,0,1
desidustat,1,0,0,0,0,1
desmond,1,0,0,0,0,1
device),0,0,0,1,0,1
dexamethasone 2 mg,0,1,0,0,0,1
dexamethasone 2 mg/ml,0,1,0,0,0,1
dexamethasone high dose,0,0,0,1,0,1
dexamethasone low dose,0,0,0,1,0,1
dexamethasone/hydroxychloroquine,0,0,0,1,0,1
dexcom,0,0,0,1,0,1
dfv890,0,1,0,0,0,1
diagnostic,0,0,0,1,0,1
diagnostic test covid-19,1,0,0,0,0,1
diagnostic test for sars-cov2 for patients,0,0,0,1,0,1
diagnostic test for sars-cov2 for patients/health staff,0,0,0,1,0,1
diagnostic tests for covid-19 infection,0,0,0,1,0,1
dialectical behavioral therapy (dbt) skills,0,0,0,1,0,1
diet,0,0,0,0,1,1
diet/sun exposure,0,0,0,0,1,1
dietary supplement,0,0,0,1,0,1
dietary supplement containing resistant starch,0,0,0,1,0,1
dietary supplementation in patients with covid disease admitted to hospital,0,0,0,1,0,1
difficulties lived by disabled children's parents in the period of covid-19 pandemic,0,1,0,0,0,1
dig axial,0,1,0,0,0,1
dig tilted,0,1,0,0,0,1
digital brochure,0,0,0,1,0,1
digital cardiac counseling,0,0,0,1,0,1
digital health online platform,0,0,0,1,0,1
digital oximeter monitoring,0,0,0,1,0,1
digital problem solving tool,0,1,0,0,0,1
digital social activity video intervention,0,1,0,0,0,1
digivis visual acuity app,0,0,0,1,0,1
dimethyl fumarate,0,0,0,1,0,1
diovan,0,0,0,1,0,1
dipyridamole er 200mg,0,0,0,1,0,1
dipyridamole er 200mg/ aspirin 25mg orally/enterally/standard of care,0,0,0,1,0,1
direct antigen tests for covid-19,0,1,0,0,0,1
direct antigen tests for sars-cov-2,0,1,0,0,0,1
discontinuation of acei,0,0,0,1,0,1
discontinuation of acei/arb,0,0,0,1,0,1
discontinuation of ras blocker,0,0,0,1,0,1
discussion board for social support /basic feedback,1,0,0,0,0,1
discussion board for social support/personalized feedback,1,0,0,0,0,1
distance learning,0,0,1,0,0,1
distilled water with the same colorant as the experimental product,0,0,0,1,0,1
disulfiram,0,0,0,1,0,1
dociparstat sodium,0,0,0,1,0,1
doppler echo,0,0,0,1,0,1
dornase alfa,0,1,0,0,0,1
dose finding phase (mtd),0,0,0,1,0,1
double-blind nt-i7,0,0,0,1,0,1
doxycyclin,0,0,0,1,0,1
doxycycline hcl,0,0,0,1,0,1
doxycyline,0,1,0,0,0,1
drugs,0,1,0,0,0,1
drugs/supportive care,0,1,0,0,0,1
ds-5670a,0,0,0,1,0,1
duact,0,0,0,1,0,1
dur-928,0,0,0,0,1,1
during hospitalization blood samples,0,0,0,1,0,1
dutasteride 0.5 mg,0,1,0,0,0,1
duty frame,1,0,0,0,0,1
dwj1248 with remdesivir,0,0,0,1,0,1
dwrx2003,0,0,0,1,0,1
early access,0,0,1,0,0,1
ec-18,0,0,0,1,0,1
ecco2r,0,0,0,1,0,1
economic benefit message,0,1,0,0,0,1
economic freedom message,0,1,0,0,0,1
eculizumab,0,0,0,1,0,1
educational program (cartoon),0,0,0,1,0,1
educational video,1,0,0,0,0,1
"educational, culturally appropriate covid-19 messages",1,0,0,0,0,1
eeg,0,1,0,0,0,1
eit-group,0,0,0,1,0,1
ejaculated semen sample,0,0,0,1,0,1
electric pad for human external pain therapy,0,0,0,1,0,1
electrical stimulation,0,0,0,1,0,1
electrical stimulation - sham,0,0,0,1,0,1
elispot,0,0,0,1,0,1
elmo project at covid-19: proof of concept,0,0,0,1,0,1
elmo project at covid-19: proof of concept/usability,0,0,0,1,0,1
elmo project at covid-19: study in humans,0,0,0,1,0,1
eltrombopag,0,0,0,1,0,1
emapalumab,0,0,0,0,1,1
embarrassment message,0,1,0,0,0,1
emdr,0,0,0,1,0,1
emergency surgical procedures,0,1,0,0,0,1
emotion regulation training via telehealth,0,0,0,1,0,1
emotional freedom technique,0,1,0,0,0,1
emotional support plan,0,0,0,1,0,1
emphasis of academic researchers involvement,1,0,0,0,0,1
emphasis of government involvement,1,0,0,0,0,1
emricasan,0,0,0,1,0,1
emtricitabine 200 mg oral tablet,0,0,0,1,0,1
emtricitabine/tenofovir,0,0,0,1,0,1
emtricitabine/tenofovir disoproxil,0,0,0,1,0,1
endoscopy,0,1,0,0,0,1
endothelial protocol,0,0,0,1,0,1
endotracheal intubation,0,0,0,1,0,1
enduring happiness,0,0,1,0,0,1
enduring happiness/continued self-enhancement (enhance) for covid-19,0,0,1,0,0,1
enhanced follow through message,0,0,1,0,0,1
enisamium iodide,0,0,0,1,0,1
enoxaparin/lovenox,0,0,0,1,0,1
enriched survey feedback,1,0,0,0,0,1
ensifentrine,1,0,0,0,0,1
ent exam,0,0,0,1,0,1
enterally,0,0,0,1,0,1
enzalutamide,0,0,0,1,0,1
ep,0,1,0,0,0,1
epic risk score display,0,0,0,1,0,1
eproms assessment,0,1,0,0,0,1
epsgun,0,0,0,1,0,1
erucov-vac,0,0,0,1,0,1
escin,0,0,0,1,0,1
essence oils,0,0,1,0,0,1
essential oil blend,0,0,0,1,0,1
estetrol monohydrate 15 mg,0,0,0,1,0,1
estradiol,0,0,0,1,0,1
estrogen therapy,0,0,0,1,0,1
ethnic frame,1,0,0,0,0,1
etoposide,0,0,0,1,0,1
eucorvac-19,0,0,0,1,0,1
exercise booklet,0,0,0,1,0,1
exercise program,0,0,0,1,0,1
exercise test ecg,0,0,0,1,0,1
exo-cd24,0,0,0,1,0,1
expanded hemodialysis for covid19 maintenance hemodialysis patients,0,0,0,1,0,1
experimental: questionnaire without precaution information,0,1,0,0,0,1
extra-cvd virtual care,0,0,0,1,0,1
extract psidii guava,0,1,0,0,0,1
eye movement desensitisation,0,0,0,1,0,1
eye movement desensitisation/reprocessing recent traumatic event protocol,0,0,0,1,0,1
f-652,0,0,0,1,0,1
face-mask niv,0,0,0,1,0,1
face mask,0,0,0,1,0,1
face mask awareness,0,0,0,1,0,1
facial mask,0,0,0,1,0,1
family nurture intervention (fni),0,0,0,1,0,1
familychildcare (provisional name of app),0,0,1,0,0,1
farmalarm,0,1,0,0,0,1
fast dissolving film,1,0,0,0,0,1
favipiravir / standard care,1,0,0,0,0,1
favipiravir/azithromycin,1,0,0,0,0,1
favipiravir/chloroquine,0,0,0,1,0,1
favipiravir/nitazoxanide,0,0,0,1,0,1
favipiravir/tocilizumab,0,0,0,1,0,1
fecal sample,0,0,0,1,0,1
fenofibrate,0,0,1,0,0,1
fenofibrate/fenofibric acid,0,0,1,0,0,1
fenofibric acid,0,0,1,0,0,1
ffp,0,0,0,1,0,1
ffp2,0,0,0,1,0,1
ffp2 respirator,0,0,0,1,0,1
ffp3 respirator,0,0,0,1,0,1
filmarray pneumonia,0,1,0,0,0,1
filtration test,0,1,0,0,0,1
fingerstick,0,0,0,1,0,1
fisetin,0,0,1,0,0,1
fixed site standard of care testing,0,0,1,0,0,1
flow controlled ventilation (evone-ventilator),0,0,0,1,0,1
fluorescein,0,1,0,0,0,1
fluoxetine,0,0,0,1,0,1
fluoxetine tablets,0,0,0,1,0,1
fluvoxamine maleate 100 mg [luvox],0,0,0,1,0,1
focused,0,0,0,1,0,1
focused/targeted message,0,0,0,1,0,1
follow-up visit,0,0,0,1,0,1
fondapariniux,0,0,0,1,0,1
fondaparinux,0,1,0,0,0,1
food diary,0,0,0,1,0,1
formoterol,0,0,0,1,0,1
fotv,0,0,0,1,0,1
foy-305,0,0,0,1,0,1
freestyle libre 14 day cgm system,0,1,0,0,0,1
fresh start,0,0,1,0,0,1
fsd201,0,0,0,1,0,1
full spectrum cbd oil,0,0,0,1,0,1
fx06,0,0,0,1,0,1
gam-covid-vac lyo,0,1,0,0,0,1
gamification,0,0,0,0,1,1
gamunex-c,0,0,0,1,0,1
ganovo,0,1,0,0,0,1
ganovo/ritonavir//-interferon nebulization,0,1,0,0,0,1
"garadacimab, factor xiia antagonist monoclonal antibody",0,1,0,0,0,1
gas exchanges at different peep,0,1,0,0,0,1
gastroscopy in transnasal techique,0,0,0,1,0,1
gbp510 (rbd 10î¼g,0,0,0,1,0,1
gbp510 (rbd 10î¼g/dose) - stage 1,0,0,0,1,0,1
gbp510 (rbd 25î¼g/dose)- stage 2,0,0,0,1,0,1
gbp510 (rbd 25î¼g/dose) - stage 1,0,0,0,1,0,1
gbp510 adjuvanted with alum (rbd 10î¼g/dose) - stage 1,0,0,0,1,0,1
gbp510 adjuvanted with alum (rbd 10î¼g/dose) - stage 2,0,0,0,1,0,1
gbp510 adjuvanted with alum (rbd 25î¼g/dose)- stage 2,0,0,0,1,0,1
gbp510 adjuvanted with alum (rbd 25î¼g/dose) - stage 1,0,0,0,1,0,1
gbp510 adjuvanted with as03 (rbd 10î¼g/dose) - stage 1,0,0,0,1,0,1
gbp510 adjuvanted with as03 (rbd 10î¼g/dose) - stage 2,0,0,0,1,0,1
gbp510 adjuvanted with as03 (rbd 25î¼g/dose)- stage 2,0,0,0,1,0,1
gbp510 adjuvanted with as03 (rbd 25î¼g/dose) - stage 1,0,0,0,1,0,1
gc4419,0,0,0,1,0,1
gc5131,0,0,0,1,0,1
general communication message,0,0,0,1,0,1
general health education,0,0,0,1,0,1
general recommendation,0,0,0,1,0,1
generic best practices,0,0,0,1,0,1
gimsilumab,1,0,0,0,0,1
gls-1200,0,0,0,1,0,1
gls-5310,0,0,0,1,0,1
gm-csf,1,0,0,0,0,1
gns561,0,0,0,1,0,1
go2 peep mouthpiece,0,1,0,0,0,1
grad-cov2,0,0,0,1,0,1
grocery store gift cards,0,0,1,0,0,1
group 1: rivaroxaban 20mg/d followed by enoxaparin/unfractionated heparin when needed,1,0,0,0,0,1
group a (ag0302-covid19),1,0,0,0,0,1
group a (placebo),1,0,0,0,0,1
group a (sample collection),0,0,0,1,0,1
group apixaban,0,1,0,0,0,1
group b (ag0302-covid19),1,0,0,0,0,1
group b (placebo),1,0,0,0,0,1
group b (sample collection),0,0,0,1,0,1
group hydroxychloroquine/apixaban,0,1,0,0,0,1
growth mindset ssi,1,0,0,0,0,1
guduchi ghan vati,0,1,0,0,0,1
guided online support program,0,0,0,1,0,1
guilt message,0,1,0,0,0,1
gx-19,0,0,0,1,0,1
gx-19n,0,0,0,1,0,1
gx-i7 vehicle,0,0,0,1,0,1
had5-s-fusion/n-etsd (suspension for injection),0,0,0,1,0,1
had5-sfusion,0,0,0,1,0,1
had5-sfusion/ n-etsd (oral capsule),0,0,0,1,0,1
hads,0,0,0,1,0,1
handwashing stations at the public places,1,0,0,0,0,1
hcfwo,0,0,0,1,0,1
health enhancement program,1,0,0,0,0,1
health literacy,0,0,0,1,0,1
health staff,0,0,0,1,0,1
health warning leaflet,0,0,0,1,0,1
healthcare providers' communication about the covid-19 vaccine,1,0,0,0,0,1
healthy lifestyle advise,0,0,0,1,0,1
healthy minds program foundations training,0,1,0,0,0,1
helmet niv,0,0,0,1,0,1
helmet non-invasive ventilation,0,0,0,1,0,1
hemodialysis by protein-leaking dialyzer for covid19 maintenance hemodialysis patients,0,0,0,1,0,1
hemodynamics changes at different peep,0,1,0,0,0,1
heparin - prophylactic dosage,0,0,0,1,0,1
heparin - therapeutic dosage,0,0,0,1,0,1
hepatitis a vaccine,1,0,0,0,0,1
herbal phenolic monoterpene,0,0,0,1,0,1
hesperidin,0,0,0,1,0,1
hfb30132a,1,0,0,0,0,1
high-dose placebo (18-59 years)/three dose regimen,0,0,0,1,0,1
high-dose placebo (18-59 years)/two dose regimen,0,0,0,1,0,1
high-dose placebo (60-85 years)/three dose regimen,0,0,0,1,0,1
high-dose placebo (60-85 years)/two dose regimen,0,0,0,1,0,1
high-dose recombinant covid-19 vaccine (sf9 cells) (18-59 years)/three dose regimen,0,0,0,1,0,1
high-dose recombinant covid-19 vaccine (sf9 cells) (18-59 years)/two dose regimen,0,0,0,1,0,1
high-dose recombinant covid-19 vaccine (sf9 cells) (60-85 years)/three dose regimen,0,0,0,1,0,1
high-dose recombinant covid-19 vaccine (sf9 cells) (60-85 years)/two dose regimen,0,0,0,1,0,1
high-dose vitamin c treatment,1,0,0,0,0,1
high-intensity aerobic training with high protein diet,0,1,0,0,0,1
high dose of kbp-covid-19,0,0,0,1,0,1
high dose radiation 100 cgy,0,0,0,1,0,1
high flow nasal therapy,0,0,0,1,0,1
high intensity interval training,0,1,0,0,0,1
high touch multi-pronged behavioral intervention,0,0,0,1,0,1
hiking challenge,1,0,0,0,0,1
hmsc,0,0,0,1,0,1
home-based exercise training,0,0,1,0,0,1
home-cov rule implementation,0,1,0,0,0,1
home care monitoring,0,0,0,0,1,1
home exercise,0,0,0,1,0,1
home pulse oximetry monitoring,0,1,0,0,0,1
home sample collection of concerning mole with physician supervision,0,1,0,0,0,1
hope intervention,1,0,0,0,0,1
"hormone levels (testosterone, fsh, lh, prolactin)",0,0,0,1,0,1
hospital telemedicine management system,0,0,0,1,0,1
hospital: dd-ca,0,0,0,1,0,1
hospital: usual care (uc),0,0,0,1,0,1
"human coach first, then virtual assistant",0,0,0,1,0,1
human recombinant interleukin 2,0,0,0,1,0,1
hydrocortisone,1,0,0,0,0,1
hydrogen oxygen generator with nebulizer,0,1,0,0,0,1
hydrogen peroxide (b) mouth rinse with the solution provided,0,0,0,1,0,1
hydroxychloroquine / metabolic cofactor supplementation,0,0,0,1,0,1
hydroxychloroquine / oxygen,0,1,0,0,0,1
hydroxychloroquine / sorbitol,0,0,0,1,0,1
hydroxychloroquine sulfate placebo,0,0,1,0,0,1
"hydroxychloroquine, lopinavir",0,0,0,1,0,1
"hydroxychloroquine, lopinavir/ritonavir/azithromycin/placebo (standard therapy)",0,0,0,1,0,1
hydroxychloroquine/azithromycin/ tocilizumab,0,1,0,0,0,1
hydroxychloroquine/clindamycin,0,1,0,0,0,1
hydroxychloroquine/doxycycline,0,1,0,0,0,1
hydroxychloroquine/lopinavir/ritonavir,0,0,0,1,0,1
hydroxychloroquine/placebo,0,0,0,0,1,1
hydroxyvitamin,0,0,0,1,0,1
hyperimmune immunoglobulin to sars-cov-2 (hivig),1,0,0,0,0,1
hyperpolarized xe129,0,0,0,1,0,1
hypothermia via cooling machine- arctic sun 5000,0,0,0,1,0,1
hypoxia : 14.3,0,0,0,1,0,1
"hypoxia : 14.3/12.7% fio2, hypercapnia 7% co2, inspiratory mechanical constraint",0,0,0,1,0,1
ibudilast,0,0,0,1,0,1
icatibant,0,0,0,1,0,1
icosapent ethyl,0,0,0,1,0,1
icosapent ethyl (ipe),0,0,0,1,0,1
icu recovery,0,0,0,1,0,1
icu recovery / physical therapy,0,0,0,1,0,1
idoine complex,0,0,0,1,0,1
ifx-1,0,0,0,1,0,1
igiv,0,0,0,1,0,1
iibr-100 high-dose (prime),0,0,0,1,0,1
iibr-100 low-dose (prime-boost),0,0,0,1,0,1
iibr-100 medium dose (prime),0,0,0,1,0,1
"iibr-100, low dose (prime)",0,0,0,1,0,1
iiv4 for the 1st dose,0,0,0,1,0,1
iiv4 for the 1st dose/ppv23 for the 2nd dose,0,0,0,1,0,1
iiv4; coviv,0,0,0,1,0,1
il-12 plasmid,1,0,0,0,0,1
imatinib mesylate intravenous solution,0,0,0,1,0,1
imm-101,0,0,0,1,0,1
immediate vs. delayed provision of antibody test results,1,0,0,0,0,1
immune globulin,0,1,0,0,0,1
immune plasma,0,0,0,1,0,1
immunofree tablets,0,1,0,0,0,1
immunofree tablets/reginmune capsule,0,1,0,0,0,1
implementation strategy,0,0,0,1,0,1
in-person postoperative visit,0,0,0,1,0,1
inactivated sars cov 2 vaccine (vero cell). wuhan,0,0,0,1,0,1
inactivated vaccine,1,0,0,0,0,1
inb03,0,0,0,1,0,1
indian costus,0,0,0,1,0,1
indomethacin,0,0,0,1,0,1
inflammation (i),0,0,0,1,0,1
inflammation (ii),0,0,0,1,0,1
inflammation (iii),0,0,0,1,0,1
inflammatory cytokines,0,0,0,1,0,1
inflammatory cytokines/chemokines profiles of patients with dexmedetomidine administration,0,0,0,1,0,1
informational sheet,0,1,0,0,0,1
inhalation of 5% sodium chloride,0,0,0,1,0,1
"inhalation of 8,4% sodium bicarbonate",0,0,0,1,0,1
inhalation of n-acetylcysteine,0,0,0,1,0,1
inhalation of vitamin c,1,0,0,0,0,1
inhaled type i interferon,0,0,0,1,0,1
injectable placebo,0,0,0,1,0,1
injection,0,0,0,1,0,1
injection of secretome-mscs,0,0,0,1,0,1
inm005,0,1,0,0,0,1
innova lateral flow device,0,0,0,1,0,1
inopulse,1,0,0,0,0,1
inspiratory muscle training,0,0,0,1,0,1
instrumental activities of daily living shaping,0,0,0,1,0,1
insulin,0,1,0,0,0,1
insulin film,1,0,0,0,0,1
insurance navigation,0,0,0,1,0,1
interferon alfa,0,0,0,1,0,1
intermediate dose enoxaparin/ unfractionated heparin,0,0,0,1,0,1
intermittent,0,0,0,0,1,1
internet-based cognitive behavioral therapy,1,0,0,0,0,1
internet-based guided self-help based on cbt principles,0,0,0,1,0,1
internet-based self-help,1,0,0,0,0,1
internet-based self-help after 3 weeks,1,0,0,0,0,1
internet-delivered cognitive behavior therapy (icbt) for dysfunctional worry related to the covid-19 pandemic,1,0,0,0,0,1
intervention app,0,1,0,0,0,1
intervention group coronacope,1,0,0,0,0,1
intervention group_rehabilitation program,0,0,0,1,0,1
intervention program,0,0,0,1,0,1
interview by psychologists,0,0,0,1,0,1
intramuscular injection,0,0,0,1,0,1
intranasal ivermectin spray,0,0,0,1,0,1
intraosseous,0,1,0,0,0,1
intravenous,0,1,0,0,0,1
intravenous drug,0,0,0,1,0,1
introductory phone call (cc,0,0,1,0,0,1
invasive mechanical ventilation using the unisabana-herons ventilator during 24 hours,0,1,0,0,0,1
investigational product - viracide,0,0,0,1,0,1
irl201104,0,0,0,1,0,1
isavuconazonium injection [cresemba],0,0,0,1,0,1
isis 721744,1,0,0,0,0,1
isoflurane inhalant product,0,0,0,1,0,1
isoquercetin,0,0,0,1,0,1
itolizumab,0,1,0,0,0,1
iv tocillizumab (tcz),0,0,0,1,0,1
ivermectin (iver pâ®) arm will receive ivm 600 âµg,0,1,0,0,0,1
ivermectin (iver pâ®) arm will receive ivm 600 âµg / kg once daily/standard care. control arm will receive standard care.,0,1,0,0,0,1
ivermectin / doxycycline / placebo,0,1,0,0,0,1
ivermectin / iota-carrageenan,0,1,0,0,0,1
ivermectin / placebo,0,1,0,0,0,1
ivermectin 3 mg,0,0,0,1,0,1
ivermectin impregnated mask,0,0,0,1,0,1
ivermectin oral tablets,0,0,0,1,0,1
ivermectin oral tablets/sublingual waffles,0,0,0,1,0,1
ivermectin pill,0,0,0,1,0,1
ivermectin powder,0,0,0,1,0,1
ivermectin/doxycycline,0,1,0,0,0,1
ivermectin/doxycyline,0,1,0,0,0,1
ivig,0,1,0,0,0,1
ixekizumab,0,0,0,1,0,1
"jinhua qinggan (jhqg) granules, traditional chinese medicine",0,0,0,1,0,1
kamada anti-sars-cov-2,0,1,0,0,0,1
kelea water,0,0,0,1,0,1
ketamine,0,0,0,1,0,1
ketogenic diet,0,0,0,1,0,1
ketogenic diet with phytoextracts,0,0,0,1,0,1
kg 24 hours continuous infusion for 15 days,0,0,0,1,0,1
kg eb05 iv,0,0,0,1,0,1
kg once daily,0,1,0,0,0,1
kg),0,0,0,1,0,1
kg;100mg,0,0,0,1,0,1
kg;50mg,0,0,0,1,0,1
kidney biopsy,1,0,0,0,0,1
kinesiotherapy protocol,0,0,0,1,0,1
kundalini yoga,0,0,0,1,0,1
kundalini yoga/anxiety reduction training,0,0,0,1,0,1
l-arginine,0,0,0,1,0,1
l. reuteri dsm 17938,0,0,0,1,0,1
l. reuteri dsm 17938 / vitamin d,0,0,0,1,0,1
lactobacillus,1,0,0,0,0,1
lactobaciltus rhamnosus gg,0,0,0,1,0,1
"lactoferrin, green tea extract",0,0,0,1,0,1
lambda 180 mcg s.c,0,0,0,1,0,1
lanadelumab placebo,0,0,0,1,0,1
laryngoscope,0,1,0,0,0,1
late dexamethazone,0,0,0,1,0,1
lau-7b,0,0,0,1,0,1
laughter theraphy,1,0,0,0,0,1
lay telephone coaching,0,0,1,0,0,1
leaf-4l6715,0,0,0,1,0,1
let it out (lio)-c,0,0,0,0,1,1
leukapheresis,0,0,0,1,0,1
levamisole,0,0,0,1,0,1
levamisole / budesonide/formoterol,0,0,0,1,0,1
levilimab,0,1,0,0,0,1
liberase enzyme,0,0,0,1,0,1
licensed seasonal influenza vaccine,0,0,0,1,0,1
licorice extract,0,0,0,1,0,1
lidocaine 2%,0,0,0,1,0,1
lifesignals biosensor 1ax*,0,0,0,1,0,1
lifestyle (exercise),0,1,0,0,0,1
lifestyle (meditation),0,1,0,0,0,1
lifestyle change promotion program,0,0,0,1,0,1
lift,0,0,0,1,0,1
limbix spark,0,0,0,1,0,1
linagliptin,0,1,0,0,0,1
linagliptin 5 mg,0,0,0,1,0,1
liposomal,0,1,0,0,0,1
liquid alpha1-proteinase inhibitor (human),0,0,0,1,0,1
"liver, lung, heart",1,0,0,0,0,1
"liver, lung, heart/kidney biopsy",1,0,0,0,0,1
longeveron mesenchymal stem cells (lmscs),0,0,0,1,0,1
longitudinally,0,0,0,1,0,1
lopinavir 200 mg,1,0,0,0,0,1
lopinavir 200 mg / ritonavir 50 mg [kaletra],1,0,0,0,0,1
lopinavir/ ritonavir/remdesivir combination,0,0,0,1,0,1
lopinavir/ritonavir / hydoxychloroquine,0,0,0,1,0,1
lopinavir/ritonavir 200 mg-50 mg oral tablet,0,0,0,1,0,1
losartan 50 mg,0,0,0,1,0,1
losartan 50 mg/spironolactone 25 mg pillules oral use,0,0,0,1,0,1
losmapimod,0,0,0,1,0,1
lovenox,0,0,0,1,0,1
low-dose placebo (18-59 years)/three dose regimen,0,0,0,1,0,1
low-dose placebo (18-59 years)/two dose regimen,0,0,0,1,0,1
low-dose placebo (60-85 years)/three dose regimen,0,0,0,1,0,1
low-dose placebo (60-85 years)/two dose regimen,0,0,0,1,0,1
low-dose recombinant covid-19 vaccine (sf9 cells) (18-59 years)/three dose regimen,0,0,0,1,0,1
low-dose recombinant covid-19 vaccine (sf9 cells) (18-59 years)/two dose regimen,0,0,0,1,0,1
low-dose recombinant covid-19 vaccine (sf9 cells) (60-85 years)/three dose regimen,0,0,0,1,0,1
low-dose recombinant covid-19 vaccine (sf9 cells) (60-85 years)/two dose regimen,0,0,0,1,0,1
low-intensity aerobic training,0,1,0,0,0,1
low-molecular-weight heparin,0,0,0,1,0,1
low dose low molecular weight heparin,0,0,0,1,0,1
low dose low molecular weight heparin/placebo,0,0,0,1,0,1
low dose of kbp-covid-19,0,0,0,1,0,1
low dose prednisolone,0,0,0,1,0,1
low/upper respiratory tract sample,0,0,0,1,0,1
lsalt peptide,0,0,0,1,0,1
lucinactant,0,0,0,1,0,1
lung impedance,0,0,0,1,0,1
lung low dose radiation,0,0,0,1,0,1
lung mechanics at different peep,0,1,0,0,0,1
lung ultrasonography,0,1,0,0,0,1
lung ultrasound use in patients hospitalized with covid,0,0,0,1,0,1
lus fourteen area,0,1,0,0,0,1
lus twelve area,0,1,0,0,0,1
lv-smenp-dc vaccine,0,0,0,1,0,1
lv-smenp-dc vaccine/antigen-specific ctls,0,0,0,1,0,1
ly3127804,0,0,0,0,1,1
lyt-100,0,0,0,1,0,1
m-m-r ii â® vaccine,0,0,0,1,0,1
m capsules 148 mg,1,0,0,0,0,1
machine learning,0,0,0,1,0,1
machine learning/ai algorithm,0,0,0,1,0,1
maf capsules 148 mg,1,0,0,0,0,1
magnesium stearate),0,0,0,1,0,1
magnetic resonance spectroscopy (mrs).,0,0,0,1,0,1
maintenance,0,0,0,1,0,1
makair,0,0,0,1,0,1
manremyc,0,0,0,1,0,1
mas825,1,0,0,0,0,1
masitinib,0,0,0,1,0,1
masked saline placebo,0,0,0,1,0,1
masseter inhibitory reflex,0,0,0,1,0,1
matrix-m1 adjuvant (crossover vaccination period),1,0,0,0,0,1
matrix-m1 adjuvant (initial vaccination period),1,0,0,0,0,1
matrix m1-adjuvant,0,0,0,1,0,1
maximal effort test,0,0,0,1,0,1
mcgrath videolaryngoscope,0,1,0,0,0,1
media intervention,0,0,0,1,0,1
medical mask,0,0,0,1,0,1
medical record review - inpatient treatment,0,0,0,1,0,1
medication review,0,0,0,1,0,1
meditation app usage,0,0,0,1,0,1
meditation therapy,0,0,0,1,0,1
meditation/anxiety reduction training,0,0,0,1,0,1
medium dosage inactivated sars-cov-2 vaccine on a 0-/14-day schedule,0,0,0,1,0,1
medium dose prednisolone,0,0,0,1,0,1
mefloquine/azithromycin/ tocilizumab,0,1,0,0,0,1
mejoracare,0,0,0,1,0,1
melatonin intravenous,0,1,0,0,0,1
melphalan,0,0,0,1,0,1
memory b-cell function,1,0,0,0,0,1
menacwy prime,0,0,0,1,0,1
menacwy prime/saline placebo boost / paracetamol,0,0,0,1,0,1
menacwy single dose,0,0,0,1,0,1
menacwy single dose / paracetamol,0,0,0,1,0,1
menacwy vaccine,0,0,0,1,0,1
mencare,0,0,1,0,0,1
mencare//bandebereho fathers'/couples' group education,0,0,1,0,0,1
mental imagery,0,0,0,1,0,1
mental well-being,0,1,0,0,0,1
meplazumab,0,0,0,1,0,1
merimepodib,0,0,0,0,1,1
mesenchymal stromal cell-based therapy,0,0,0,1,0,1
mesenchymalÂ stem cells/heparin,0,1,0,0,0,1
mesencure,0,0,0,1,0,1
messaging,0,1,0,0,0,1
metabolic cofactor supplementation,0,0,0,1,0,1
metenkefalin,0,1,0,0,0,1
metenkefalin / tridecactide,0,1,0,0,0,1
metformin,0,0,0,1,0,1
metformin extended release oral tablet,0,0,0,1,0,1
metformin glycinate,0,0,0,1,0,1
methotrexate-lde phase 1,0,0,0,1,0,1
methotrexate-lde phase 2,0,0,0,1,0,1
methylene-blue photodisinfection,0,0,0,1,0,1
methylene blue/ vitamin c/n-acetyl cysteine,0,0,0,1,0,1
methylprednisolone injectable product,0,0,0,1,0,1
methylprednisolone injection,0,1,0,0,0,1
mfs,0,0,0,1,0,1
mhealth assessments,0,0,0,1,0,1
mhealth platform,0,0,0,1,0,1
microbiome spray,0,0,0,1,0,1
micronized,0,0,0,1,0,1
"micronized/ultra-micronized palmitoylethanolamide (mpea/umpea, 300mg / 600mg) oral suspension",0,0,0,1,0,1
mindfullness training,0,1,0,0,0,1
mindfulness-based cognitive therapy,0,0,0,1,0,1
mindfulness-based stress reduction,0,0,0,1,0,1
mindfulness session(s),1,0,0,0,0,1
minimal attention control intervention,0,0,0,0,1,1
miniprobe alveoflex,0,0,0,1,0,1
"minus formula, huhuang detoxicity paste, baimu qingre jiedu paste, fumigation",1,0,0,0,0,1
ml intravenous solution [actemra]_#1,0,0,0,1,0,1
ml intravenous solution [actemra]_#1 (2 doses),0,0,0,1,0,1
ml prefilled syringe [kineret],0,0,0,1,0,1
mls laser,0,1,0,0,0,1
mobile mental health app - 1,0,0,1,0,0,1
mobile mental health app - 2,0,0,1,0,0,1
mobile mental health app - 3,0,0,1,0,0,1
mobile mental health app - 4,0,0,1,0,0,1
moderate intensity aerobic exercises,0,1,0,0,0,1
modified ipac-uhn ppe,0,0,0,1,0,1
molecular hydrogen,0,0,0,1,0,1
molgramostim nebuliser solution,0,0,0,1,0,1
molixan,0,0,0,1,0,1
mometasone furoate nasal spray,0,1,0,0,0,1
mon002,0,0,0,1,0,1
monalizumab,0,0,0,1,0,1
monitoring,0,0,0,1,0,1
monoclonal antibody,0,0,0,1,0,1
montmorrillonite,0,1,0,0,0,1
motivational interviewing/covid-19 symptom monitoring system,0,0,0,1,0,1
motivational messages,1,0,0,0,0,1
mouthrinse with bãªta-cyclodextrin,0,1,0,0,0,1
mouthrinse with bãªta-cyclodextrin/citrox,0,1,0,0,0,1
mouthrinse without bãªta-cyclodextrin,0,1,0,0,0,1
mouthrinse without bãªta-cyclodextrin/citrox,0,1,0,0,0,1
moxibustion,0,0,0,1,0,1
moxibustion/cupping,0,0,0,1,0,1
mr,0,0,0,1,0,1
mr/m-m-r ii â® vaccine,0,0,0,1,0,1
mrg-001,0,0,0,1,0,1
mrna-1273.351,1,0,0,0,0,1
mrna-1283,0,0,0,1,0,1
mrx-4dp0004,0,0,0,1,0,1
msc,0,0,0,1,0,1
mstt1041a,0,1,0,0,0,1
mucodentol,0,0,0,1,0,1
multipeptide cocktail,0,0,0,1,0,1
multistem,0,0,0,1,0,1
multivitamin with 11mg of zinc,1,0,0,0,0,1
muscle biopsy,0,0,0,1,0,1
muscle relaxation therapy,0,0,0,1,0,1
mva-sars-2-s vaccinations (days 0,0,0,0,1,0,1
mva-sars-2-s vaccinations (days 0/28),0,0,0,1,0,1
mvc-cov1901,1,0,0,0,0,1
mvc-cov1901(s protein with adjuvant),1,0,0,0,0,1
mvc-cov1901(saline),1,0,0,0,0,1
mw33 injection,0,0,0,1,0,1
mw33 injection placebo,0,0,0,1,0,1
n-acetyl glucosamine (nag),1,0,0,0,0,1
n-etsd (oral capsule),0,0,0,1,0,1
n-etsd (suspension for injection),0,0,0,1,0,1
n95 respirator,0,0,0,1,0,1
na-831/atazanavir,0,0,0,1,0,1
na-831/dexamethasone,0,0,0,1,0,1
nad,0,0,0,1,0,1
nad/,0,0,0,1,0,1
naproxen,0,0,0,0,1,1
nasal,0,0,0,1,0,1
nasal irrigation,0,0,0,1,0,1
nasal lavage,0,0,1,0,0,1
nasopharyngeal,0,0,0,1,0,1
nasopharyngeal samples.,0,0,0,1,0,1
nasopharyngeal/throat/oropharyngeal swabs analyses by rt-pcr/ddpcr,0,0,0,1,0,1
nasopharynx,0,0,0,0,1,1
nasovax,0,0,0,1,0,1
navigation services,0,0,0,1,0,1
nbp2001 adjuvanted with alum (rbd 30î¼g,1,0,0,0,0,1
nbp2001 adjuvanted with alum (rbd 30î¼g/dose),1,0,0,0,0,1
nbp2001 adjuvanted with alum (rbd 50î¼g,1,0,0,0,0,1
nbp2001 adjuvanted with alum (rbd 50î¼g/dose),1,0,0,0,0,1
nbt-nm108,0,0,0,1,0,1
nebivolol,0,0,0,1,0,1
nebulised heparin,0,0,0,1,0,1
nebulised recombinant tissue-plasminogen activator (rt-pa),0,0,0,1,0,1
nebulised unfractionated heparin (ufh),0,0,0,1,0,1
nebulized administration of rlf-100,0,0,0,1,0,1
nebulized administration of rlf-100/placebo,0,0,0,1,0,1
nebulized furosemide,0,0,0,1,0,1
nebulized platelet lysate,1,0,0,0,0,1
nebulized saline,0,0,0,1,0,1
nebulized sterile saline,1,0,0,0,0,1
neurocognitive assessment,0,0,0,1,0,1
neurology test,0,0,1,0,0,1
neuromuscular,0,0,0,1,0,1
neutral writing control,0,0,0,0,1,1
new ppe,0,1,0,0,0,1
news,0,0,0,0,1,1
ng test,0,0,0,1,0,1
ngm621,0,0,0,1,0,1
niclosamide / camostat,0,0,0,1,0,1
niclosamide oral tablet,0,0,0,1,0,1
niclosamide suspension,0,0,0,1,0,1
nicorandil,0,0,0,1,0,1
nicotinamide,0,0,0,1,0,1
nicotinamide riboside,0,0,0,1,0,1
nicotine 7 mg,0,0,0,1,0,1
nicotine 7 mg/ 24h transdermal patch - 24 hour,0,0,0,1,0,1
nicotine patch,0,0,0,1,0,1
nigella sativa / black cumin,0,1,0,0,0,1
nigella sativa seed,0,0,0,1,0,1
nintedanib,0,0,0,1,0,1
nintedanib 150 mg [ofev],0,0,0,1,0,1
nitazoxanide/atazanavir/ritonavir,0,0,0,1,0,1
"nitric oxide lozenges, 30 mg",0,0,0,1,0,1
nitroglycerin,0,0,0,1,0,1
nk-1r antagonist,0,0,0,1,0,1
no activities of the hbcc project,1,0,0,0,0,1
no instruction regarding positioning,0,0,0,1,0,1
no messaging,1,0,0,0,0,1
no personal protective equipment (ppe),0,1,0,0,0,1
no racial inequality highlighting,1,0,0,0,0,1
no research related technology based social interactions,0,0,1,0,0,1
non-contact mce system,0,1,0,0,0,1
non-mindfulness intervention,0,1,0,0,0,1
non-operative management,0,0,1,0,0,1
normal saline intranasal,0,0,0,1,0,1
not bravery message,0,1,0,0,0,1
nowdx covid-19 test,0,1,0,0,0,1
nox66,0,0,0,1,0,1
np-120 (ifenprodil),1,0,0,0,0,1
nudge,0,0,0,0,1,1
nutrition consult,0,0,0,1,0,1
nutrition consult/protein supplementation,0,0,0,1,0,1
nuvastatic,0,0,0,1,0,1
observation,0,0,0,1,0,1
obvio-19 app,0,0,0,1,0,1
octaplas,0,0,0,1,0,1
old ppe,0,1,0,0,0,1
olfactometry,0,0,0,1,0,1
olokizumab,0,1,0,0,0,1
omega 3/nigella sativa oil,0,0,0,1,0,1
omega 3/nigella sativa oil/anise seed capsule,0,0,0,1,0,1
omega 3/nigella sativa oil/deglycyrrhizinated licorice,0,0,0,1,0,1
omega 3/nigella sativa oil/indian costus,0,0,0,1,0,1
omega 3/nigella sativa oil/quinine pills,0,0,0,1,0,1
omeprazole,0,0,0,1,0,1
omnibiotic aad,0,0,0,1,0,1
on-site testing (lumiradx),0,0,0,1,0,1
one covid-19 vaccine candidate (tmv-083) administration - high dose,0,0,0,1,0,1
online cognitive stimulation therapy,0,0,0,1,0,1
online intervention grief covid-19,0,0,0,1,0,1
online intervention mental health covid-19,0,0,0,1,0,1
online kkh sports singapore program with usual care,0,0,0,1,0,1
online lifestyle intervention,0,0,0,1,0,1
online questionnaires,0,0,0,1,0,1
online self-help intervention,1,0,0,0,0,1
op-101,0,0,0,1,0,1
open label bss (pepto bismol),0,0,0,1,0,1
operative management,0,0,1,0,0,1
ophtamesone,0,0,0,1,0,1
opt-in recruitment email,0,1,0,0,0,1
opt-out recruitment email,0,1,0,0,0,1
optical coherence tomography (oct),0,0,0,1,0,1
or high dose lmwh),0,0,0,1,0,1
"or psychotherapy, n=10)",1,0,0,0,0,1
oral,0,0,0,1,0,1
oral intervention with cetylpyridinium chloride,0,0,0,1,0,1
oral ivermectin,0,0,0,1,0,1
oral polio vaccine / information,0,0,1,0,0,1
oropharyngeal swabs analyses by rt-pcr,0,0,0,1,0,1
ortd-1 high dose,0,0,0,1,0,1
ortd-1 low dose,0,0,0,1,0,1
ortd-1 mid dose,0,0,0,1,0,1
oseltamivir 75mg,0,0,0,1,0,1
otilimab,0,0,0,1,0,1
oxaloacetate medical food,0,0,0,1,0,1
oxaloacetate medical food/dietary supplement,0,0,0,1,0,1
oxygen mask,0,0,0,1,0,1
oxyhydrogen,0,0,0,1,0,1
ozanimod,0,0,0,1,0,1
ozone,0,0,0,1,0,1
p2et (caesalpinia spinosa extract),0,0,0,1,0,1
p2y12,0,0,0,1,0,1
pacritinib,0,0,0,1,0,1
pamrevlumab,0,0,0,1,0,1
parentchat for parents of children ages 2-17,0,0,0,1,0,1
parents during induction,0,0,0,1,0,1
part 1 - tl-895,0,0,0,1,0,1
part 2 - tl-895,0,0,0,1,0,1
part a,0,0,0,1,0,1
part a/b: placebo,0,0,0,1,0,1
part a: upamostat 200 mg,0,0,0,1,0,1
part a: upamostat 400 mg,0,0,0,1,0,1
part b: upamostat 200,0,0,0,1,0,1
part b: upamostat 200/400 mg,0,0,0,1,0,1
partially hla-matched sars-covsts,0,0,0,1,0,1
participate in a massive musical event,0,1,0,0,0,1
particle measurement,0,1,0,0,0,1
passive microwave radiometry,0,1,0,0,0,1
"patch, nicotine",0,0,0,1,0,1
"patch, placebo",0,0,0,1,0,1
patient-centred advice on telephone consultation in tb patients:,0,0,0,1,0,1
patient educational video,0,0,1,0,0,1
patient mychart scheduling link,0,0,1,0,0,1
patient status engine,0,0,0,1,0,1
patients covid 19,0,0,0,1,0,1
pbmt,0,1,0,0,0,1
pbmt/smf,0,1,0,0,0,1
pcr/serology,0,0,0,1,0,1
peer resilience champion,1,0,0,0,0,1
peginterferon beta-1a,0,0,0,1,0,1
pembrolizumab,0,0,0,1,0,1
pemziviptadil (pb1046),0,0,0,0,1,1
pentaglobin,0,0,0,1,0,1
pentoxifylline,1,0,0,0,0,1
pep flute,1,0,0,0,0,1
performance of the test antigenic,0,1,0,0,0,1
performance of the test antigenic/test rt-pcr,0,1,0,0,0,1
performing of lung ultrasound,0,0,0,1,0,1
peripheral venous ultrasound,0,0,0,1,0,1
personal freedom message,0,1,0,0,0,1
personal protective equipment,0,0,0,1,0,1
personal protective equipment (ppe),0,1,0,0,0,1
personal protective measures,0,1,0,0,0,1
personalized health education,0,0,0,1,0,1
pf-06650833,0,0,0,1,0,1
pf-07304814,0,0,0,1,0,1
phr160 spray,0,0,0,1,0,1
physical,0,0,0,1,0,1
physical/cognitive activity,0,0,0,1,0,1
physiological effects of awake prone position in covid 19 patients,0,0,0,1,0,1
physiotherapy,0,1,0,0,0,1
phytomedicine,0,0,1,0,0,1
piclidenoson,0,0,0,1,0,1
pioglitazone,0,1,0,0,0,1
pioglitazone 30 mg,0,0,0,1,0,1
pioglitazone 45 mg,0,0,0,1,0,1
piperacillin,0,0,0,1,0,1
piperacillin/tazobactam,0,0,0,1,0,1
placebo-lde phase 2,0,0,0,1,0,1
placebo-simulation of transcranial direct current stimulation,0,0,0,1,0,1
placebo - phase i,1,0,0,0,0,1
placebo (crossover vaccination period),1,0,0,0,0,1
placebo (im),0,0,0,1,0,1
placebo (inhaled solution),0,0,0,1,0,1
placebo (initial vaccination period),1,0,0,0,0,1
placebo (iv),0,0,0,1,0,1
placebo (methylcellulose) capsule,0,0,0,1,0,1
placebo (oral tablet),0,0,0,1,0,1
placebo (potato starch,0,0,0,1,0,1
placebo (potato starch/magnesium stearate),0,0,0,1,0,1
placebo (saline),0,0,0,1,0,1
"placebo (sodium chloride, a 0.9% solution for the preparation of dosage forms for injections)",1,0,0,0,0,1
placebo (standard therapy),0,0,0,1,0,1
"placebo (two doses), priming",1,0,0,0,0,1
placebo / soc,0,0,0,1,0,1
placebo / vitamin d,0,0,0,1,0,1
placebo 1,0,0,0,1,0,1
placebo 2,0,0,0,1,0,1
placebo booster,1,0,0,0,0,1
placebo control (non-behavioral infographic),0,1,0,0,0,1
placebo empty capsule,0,0,0,1,0,1
placebo for abbv-2b04,0,0,0,1,0,1
placebo for abbv-47d11,0,0,0,1,0,1
placebo for camostat mesilate,0,0,0,1,0,1
placebo hydroxychloroquine,0,0,0,1,0,1
placebo iv,0,0,0,1,0,1
placebo magnesium,0,0,0,1,0,1
placebo nitazoxanide,0,0,0,1,0,1
placebo of fx06,0,0,0,1,0,1
placebo of nicotine transdermal patch,0,0,0,1,0,1
placebo oil,0,0,0,1,0,1
placebo patch,0,0,0,1,0,1
placebo ribavirin,0,0,0,1,0,1
placebo spray,0,0,0,1,0,1
placebo videos,1,0,0,0,0,1
placebo with remdesivir,0,0,0,1,0,1
placebo/aluminum adjuvant of inactivated sars-cov-2 vaccine,1,0,0,0,0,1
placebo/control,0,0,0,1,0,1
plasma exchange/convalescent plasma,0,0,0,1,0,1
pln-74809,0,0,0,1,0,1
pneumococcal vaccine,1,0,0,0,0,1
polio vaccine,0,0,1,0,0,1
polio vaccine/na-831,0,0,1,0,0,1
poractant alfa,0,0,0,1,0,1
position,0,0,0,1,0,1
positive feedback,0,1,0,0,0,1
postural positioning,0,0,0,1,0,1
povidone,0,0,0,1,0,1
power breathe,0,0,0,0,1,1
ppv23,0,0,0,1,0,1
ppv23 for the 2nd dose,0,0,0,1,0,1
prazosin,0,0,0,1,0,1
prediction market,0,1,0,0,0,1
prednisone tablet,0,0,0,1,0,1
preservision areds formulation soft gels,1,0,0,0,0,1
preservision areds formulation soft gels/tablets,1,0,0,0,0,1
primary care,0,1,0,0,0,1
primepro,0,1,0,0,0,1
pro-sero-cov,1,0,0,0,0,1
probiorinse,0,0,0,1,0,1
probiotics,0,1,0,0,0,1
probiotics (2 strains 10x10^9 ufc),0,0,0,1,0,1
problem-solving,0,0,0,1,0,1
problem-solving/relationship improvement intervention.,0,0,0,1,0,1
procalcitonin,0,0,0,1,0,1
produce prescription program,0,0,1,0,0,1
progesterone,0,1,0,0,0,1
progressive cycling exercise test to exhaustion,0,1,0,0,0,1
progressive muscle relaxation,0,1,0,0,0,1
project echo,0,0,0,1,0,1
prolastin,0,0,0,1,0,1
prolectin-m; a (1-6)-alpha-d-mannopyranose class,0,1,0,0,0,1
prolonged proned positioning,0,0,0,1,0,1
promotores de salud,0,0,0,1,0,1
prophylactic,0,0,0,1,0,1
prophylaxis,0,1,0,0,0,1
propofol,0,0,0,1,0,1
prosocial-benefit,0,0,1,0,0,1
protective ventilation,0,0,0,1,0,1
protein supplementation,0,0,0,1,0,1
prototype,0,0,0,1,0,1
psc-04,0,0,0,1,0,1
psg,0,0,0,1,0,1
psycho-education video,0,0,0,1,0,1
psychoeducation,0,0,0,1,0,1
psychoeducational intervention,0,0,0,1,0,1
psychological,0,0,0,1,0,1
psychological rehabilitation,0,0,0,1,0,1
psychological triaging intervention,0,1,0,0,0,1
psychological/behaviour change support,0,0,0,1,0,1
psychotherapy,0,0,0,1,0,1
ptc299,0,0,0,1,0,1
ptx-covid19-b,0,0,0,1,0,1
pulmonary anomalies 4 months after documented covid-19 pneumonia,1,0,0,0,0,1
pulmonary function testing,0,0,0,1,0,1
pulmonary physiotherapy techniques,0,1,0,0,0,1
pulmonary tele-rehabilitation,0,0,0,1,0,1
pulmozyme/ recombinant human deoxyribonuclease (rh-dnase),0,0,0,1,0,1
pulse oximeter,1,0,0,0,0,1
pulse oximetry,0,1,0,0,0,1
pyridostigmine bromide,0,0,0,1,0,1
pyronaridine-artesunate (pa),0,0,0,1,0,1
qrt-pcr,0,0,1,0,0,1
qrt-pcr/serology,0,0,1,0,0,1
quadramune(tm),0,0,0,1,0,1
qualitative,0,0,0,1,0,1
qualitative/quantitative virus pcr of respiratory secretions in patients with high aerosol concentrations,0,0,0,1,0,1
quality of life promotion,1,0,0,0,0,1
quantitative virus pcr of respiratory secretions in patients with high aerosol concentrations,0,0,0,1,0,1
quercetin phytosome,0,0,0,1,0,1
quinine,0,0,0,1,0,1
quinquina-stevia,0,0,1,0,0,1
quinquina-stevia/azythromycin,0,0,1,0,0,1
r tablets,1,0,0,0,0,1
racial,1,0,0,0,0,1
racial inequality highlighted,1,0,0,0,0,1
racial/ethnic frame,1,0,0,0,0,1
radiological,0,0,0,1,0,1
radius ppg tetherless pulse oximetry (masimo),0,0,0,1,0,1
radx chcs testing intervention strategy,0,0,0,1,0,1
ramipril,0,0,0,1,0,1
randomized booster,1,0,0,0,0,1
rapa-501-allo off-the-shelf therapy of covid-19,0,0,0,1,0,1
rapid antigen test,0,0,0,1,0,1
rapid salivary test,0,1,0,0,0,1
rayaldee 30mcg extended-release (er) capsule,0,0,0,1,0,1
razuprotafib,0,0,0,1,0,1
razuprotafib subcutaneous solution,0,0,0,1,0,1
rbt-9 (90 mg),0,0,0,1,0,1
rd-x19,0,1,0,0,0,1
rdv,0,0,0,1,0,1
rdv placebo,0,0,0,1,0,1
reading a book,0,1,0,0,0,1
recharge,0,0,0,1,0,1
recombinant human anti-sars-cov-2 monoclonal antibody(25mg,0,0,0,1,0,1
recombinant human anti-sars-cov-2 monoclonal antibody(25mg/kg;50mg/kg;100mg/kg),0,0,0,1,0,1
recombinant human plasma gelsolin (rhu-pgsn),1,0,0,0,0,1
recombinant new coronavirus vaccine (cho cell) group,0,0,0,1,0,1
recombinant novel coronavirus vaccine (adenovirus type 5 vector) -placebo,0,0,0,1,0,1
rectal swab,0,0,0,1,0,1
referral,0,0,0,1,0,1
referral card,0,0,0,1,0,1
referral/digital brochure,0,0,0,1,0,1
reframing,0,1,0,0,0,1
reginmune,0,1,0,0,0,1
regular care,0,0,0,1,0,1
rehabilitation,0,1,0,0,0,1
rehabilitation by concentric exercises,0,0,0,1,0,1
rehabilitation by eccentric exercises,0,0,0,1,0,1
rehabilitation of cognitive function after remission of the symptoms of covid-19,0,0,0,1,0,1
rehabilitation protocol through a digital platform,0,0,0,1,0,1
rejuveinix (rjx) active comparator,0,0,0,1,0,1
relationship improvement intervention.,0,0,0,1,0,1
relaxation,0,0,0,1,0,1
remain covid free ssi,0,1,0,0,0,1
remdesivir-hu,1,0,0,0,0,1
remdesivir combination,0,0,0,1,0,1
remestemcel-l,1,0,0,0,0,1
remote cognitive behavioral therapy for insomnia,0,0,0,1,0,1
remote controlled exercise,0,0,0,1,0,1
remote problem management plus,0,0,0,1,0,1
"remote sms (short message service, also known as ""text message"") delivery",0,0,0,1,0,1
removal of dead space filter,0,0,0,1,0,1
renin-angiotensin system inhibitors,0,0,0,1,0,1
reparixin,0,0,0,0,1,1
reprocessing recent traumatic event protocol,0,0,0,1,0,1
resilience program,0,0,0,1,0,1
resistance training,0,0,1,0,0,1
resp-aer-meter,0,0,0,1,0,1
"resp301, a nitric oxide generating solution",0,0,0,1,0,1
respiratory,0,0,0,1,0,1
respiratory function rehabilitation training,0,0,0,1,0,1
respiratory rehabilitation program (rr).,0,0,0,1,0,1
respiratory tele-rehabilitation program (trr).,0,0,0,1,0,1
respiratory tract sample,0,0,0,1,0,1
respiratory training,0,0,0,1,0,1
respiratory/psychological rehabilitation,0,0,0,1,0,1
resting 12 lead ecg,0,0,0,1,0,1
revised home-cov score,0,1,0,0,0,1
reward re-training,0,0,0,1,0,1
rh-dnase,0,0,0,1,0,1
rhace2,0,1,0,0,0,1
rhdnase i,0,0,0,1,0,1
rhinopharyngeal,0,1,0,0,0,1
rhtpo,0,0,0,1,0,1
rintatolimod,0,0,0,1,0,1
risankizumab,0,0,0,1,0,1
ritonavir 200 mg-50 mg oral tablet,0,0,0,1,0,1
ritonavir 50 mg [kaletra],1,0,0,0,0,1
ritonavir/oseltamivir,0,0,0,1,0,1
rivaroxaban 15mg tab,0,0,0,1,0,1
rlf-100 (aviptadil),0,0,0,1,0,1
rnapc2,0,0,0,1,0,1
robot assisted percutaneous cardiovascular intervention,0,0,0,1,0,1
robotic assisted early mobilization,0,0,0,1,0,1
robotic therapy,0,0,0,1,0,1
routine care (no sars-covsts),0,0,0,1,0,1
routine psychological support,0,1,0,0,0,1
rph-104,0,1,0,0,0,1
rt-qpcr test,0,1,0,0,0,1
sab-185,1,0,0,0,0,1
saline-sodium citrate (ssc) buffer,0,0,0,1,0,1
saline placebo boost,0,0,0,1,0,1
saline with baby shampoo nasal irrigation,1,0,0,0,0,1
saline/standard care,0,1,0,0,0,1
saliva assay,0,0,1,0,0,1
saliva collected via salivette cortisol,0,1,0,0,0,1
saliva test kit,0,0,0,1,0,1
sam-lnp-s,0,0,0,1,0,1
sam-lnp-s-tce,0,0,0,1,0,1
sample,0,0,0,1,0,1
sample collection/performance evaluation (a),0,0,0,1,0,1
sample collection/performance evaluation (b),0,0,0,1,0,1
sampler skills,0,0,0,1,0,1
sampling,0,0,0,1,0,1
sampling by venipuncture (and eventually by nasopharyngeal swab),0,0,0,1,0,1
sampling of oropharynx,0,0,0,0,1,1
sampling of oropharynx/nasopharynx,0,0,0,0,1,1
sampling of sars-cov-2 rna from nasopharyngeal swab specimen,0,1,0,0,0,1
sampling of sars-cov-2 rna from nasopharyngeal swab specimen/saliva collected via salivette cortisol,0,1,0,0,0,1
sar443122,0,1,0,0,0,1
sarilumab prefilled syringe,0,0,0,1,0,1
sars-cov-2 antibody based ivig therapy,0,1,0,0,0,1
sars-cov-2 antibody test,0,0,0,1,0,1
sars-cov-2 antigen-specific cytotoxic t-lymphocytes,0,0,0,1,0,1
sars-cov-2 ig g levels,0,0,0,1,0,1
sars-cov-2 inactivated vaccine,0,0,0,1,0,1
sars-cov-2 infection,1,0,0,0,0,1
sars-cov-2 mrna vaccine formulation 1,0,0,0,1,0,1
sars-cov-2 mrna vaccine formulation 2,0,0,0,1,0,1
sars-cov-2 mrna vaccine formulation 3,0,0,0,1,0,1
sars-cov-2 neutralizing antibody titer,0,0,0,1,0,1
sars-cov-2 recombinant protein vaccine formulation 1,1,0,0,0,0,1
sars-cov-2 recombinant protein vaccine formulation 2,1,0,0,0,0,1
sars-cov-2 recombinant protein vaccine formulation 3,1,0,0,0,0,1
"sars-cov-2 research in nasopharyngeal swab, sperm",0,0,0,1,0,1
"sars-cov-2 research in nasopharyngeal swab, sperm/serologics",0,0,0,1,0,1
sars-cov-2 rs/matrix-m1 adjuvant (crossover vaccination period),1,0,0,0,0,1
sars-cov-2 rs/matrix-m1 adjuvant (initial vaccination period),1,0,0,0,0,1
sars-cov-2 rs/matrix m1-adjuvant,0,0,0,1,0,1
sars-cov-2 rt-pcr assay for detection of covid-19 infection,0,0,0,1,0,1
sars-cov-2 specific t cells,0,0,0,1,0,1
sars-cov-2 testing on the eppendorf thermal cycler pcr system using self-collected saliva as the specimen,0,0,0,1,0,1
sars-cov-2 vaccine formulation 1 with adjuvant 1,1,0,0,0,0,1
sars-cov-2 vaccine formulation 1 with adjuvant 2,1,0,0,0,0,1
sars-cov-2 vaccine formulation 2 with adjuvant 1,1,0,0,0,0,1
sars-cov-2 vaccine formulation 2 with adjuvant 2,1,0,0,0,0,1
sars-cov-2 vaccine formulation 2 without adjuvant,1,0,0,0,0,1
sars-cov-2 viral composition,0,0,0,1,0,1
sbi-101,0,0,0,1,0,1
scarcity message,0,1,0,0,0,1
scb-2019,1,0,0,0,0,1
scb-2019 with as03 adjuvant,1,0,0,0,0,1
scb-2019 with cpg 1018 adjuvant,1,0,0,0,0,1
scb-2019 with cpg 1018 adjuvant/alum adjuvant,1,0,0,0,0,1
scd,0,0,0,1,0,1
sch intervention,0,0,1,0,0,1
scta01,0,1,0,0,0,1
self-benefit,0,0,1,0,0,1
self-care tools,0,0,1,0,0,1
"self-collected, home-based testing",0,0,1,0,0,1
self-compassion for chronic pain virtual group treatment program,0,0,0,1,0,1
self-help booklet,0,1,0,0,0,1
self-help mindfulness,0,0,0,1,0,1
self-help mindfulness/compassion exercises,0,0,0,1,0,1
self-interest message,0,1,0,0,0,1
self-management booklet (switch: stay well during covid-19),1,0,0,0,0,1
self-questionnary,0,0,0,1,0,1
self measurement with pulse oximeter,0,0,0,1,0,1
self study,0,0,0,1,0,1
senicapoc,0,0,0,1,0,1
sequence of testing.,0,0,0,1,0,1
serological testing for covid-19 infection,0,0,0,1,0,1
serological tests for sars cov-2,0,1,0,0,0,1
serology test follow-up,1,0,0,0,0,1
serology to determine sars-cov-2 infection,0,0,0,1,0,1
serum,1,0,0,0,0,1
services as usual,0,0,0,1,0,1
sessions,1,0,0,0,0,1
severity of lung involvement with covid-19.,0,1,0,0,0,1
sfc (5-ala,0,0,0,1,0,1
sfc),0,0,0,1,0,1
sham inflation,0,0,0,1,0,1
shanshamani vati plus,0,1,0,0,0,1
shared decision making,0,0,1,0,0,1
shg,0,1,0,0,0,1
"shingrix (zoster vaccine recombinant, adjuvanted)",0,0,0,1,0,1
sildenafil,0,0,0,1,0,1
sildenafil citrate,0,0,0,1,0,1
simha kriya,0,1,0,0,0,1
simple cognitive task,0,1,0,0,0,1
simulation intervention,0,0,0,1,0,1
simvastatin,0,0,0,1,0,1
single high dose vitamin d,0,0,0,1,0,1
singstrong: strong lungs through song,0,0,0,1,0,1
sirukumab,0,0,0,1,0,1
sit-to-stand test,0,0,0,1,0,1
sit to stand test,0,0,0,1,0,1
sivomixx,0,0,0,1,0,1
sledd with a l-mod,0,0,0,1,0,1
sm-ema,0,0,0,1,0,1
smell training,0,0,0,1,0,1
sms-based support,0,0,0,1,0,1
sms message support,0,1,0,0,0,1
soc / ifx-1,0,0,0,1,0,1
soc / intravenous famotidine,0,1,0,0,0,1
soc/15mg/kg eb05 iv,0,0,0,1,0,1
soc/placebo iv,0,0,0,1,0,1
social proof,0,1,0,0,0,1
socialization,0,0,0,1,0,1
sodium chloride,0,0,0,1,0,1
"sodium chloride, 0.9%",0,0,0,1,0,1
sofosbuvir 400 mg,0,0,0,1,0,1
sofosbuvir 400 mg/daclatasvir 200mg,0,0,0,1,0,1
sofosbuvir ledipsavir,0,0,0,1,0,1
solution-focused support program,0,0,0,1,0,1
sorbitol,0,0,0,1,0,1
soterix tavns model 0125-lte stimulator - active-active group,0,0,0,1,0,1
soterix tavns model 0125-lte stimulator - sham-active group,0,0,0,1,0,1
spartan covid-19 platform,0,0,0,1,0,1
spartan covid-19 system,0,1,0,0,0,1
specific exercise rehabilitation treatment,0,0,0,1,0,1
specimens specific for the study,0,0,0,1,0,1
speed of processing training,0,0,0,1,0,1
sperm test,0,0,0,1,0,1
sphenopalatine ganglion block with local anesthetic,0,0,0,1,0,1
sphenopalatine ganglion block with placebo (isotone nacl),0,0,0,1,0,1
spin-chat program,0,1,0,0,0,1
spirometry,0,0,0,1,0,1
spironolactone 25 mg pillules oral use,0,0,0,1,0,1
sputnik light,1,0,0,0,0,1
sse educational intervention,0,1,0,0,0,1
st266,0,0,0,1,0,1
staff wellbeing centres,0,0,0,1,0,1
standard care/monitoring,0,0,0,1,0,1
standard care/placebo,0,0,0,1,0,1
standard charity resources,0,0,0,1,0,1
standard interface,0,1,0,0,0,1
standard of care (soc)/colchicine/rosuvastatin,0,0,0,1,0,1
standard of care thromboprophylaxis,0,0,0,1,0,1
standard oxygen delivery system,0,1,0,0,0,1
standard prophylactic dose enoxaparin,0,0,0,1,0,1
standard prophylactic dose enoxaparin/ unfractionated heparin,0,0,0,1,0,1
"standard q covid-19 ag - test, produced by sd biosensor inc.",0,1,0,0,0,1
standard therapy for covid-19 patient,0,1,0,0,0,1
standard therapy protocol (stp),0,0,0,1,0,1
standard treatment of covid-19,0,0,0,1,0,1
steam inhalations,0,0,0,1,0,1
stellate ganglion block,0,0,0,1,0,1
steroid taper (prednisone),0,0,0,1,0,1
sti-5656,0,0,0,1,0,1
stigma awareness video intervention,0,1,0,0,0,1
stimulation test with arginine infusion in order to verify the possible existence of damage to the beta cell function induced by covid-19 infection,0,0,0,1,0,1
stool analysis,0,0,0,1,0,1
stools,0,0,0,1,0,1
stp / covid-19 convalescent plasma (cp),0,0,0,1,0,1
stp / standard plasma (sp),0,0,0,1,0,1
stress first aid,0,0,0,1,0,1
sublingual methylene blue,0,0,0,1,0,1
sublingual micro-dose ketamine,1,0,0,0,0,1
sublingual waffles,0,0,0,1,0,1
sudarshan kriya yoga (sky),1,0,0,0,0,1
sulfur hexafluoride lipid-type a microspheres,0,0,0,1,0,1
sulodexide,0,1,0,0,0,1
sun exposure,0,0,0,0,1,1
supine position,0,0,0,1,0,1
supine positioning,0,0,0,1,0,1
support as usual,0,0,0,1,0,1
supportive services,0,0,0,1,0,1
supportive therapy,0,0,0,1,0,1
supportive therapy ssi,1,0,0,0,0,1
supportive tratment,0,0,0,1,0,1
supportive/symptomatic treatment,1,0,0,0,0,1
surgical face mask use only,1,0,0,0,0,1
surgical facial mask,0,1,0,0,0,1
suspension,0,0,0,1,0,1
suspension/maintenance of angiotensin receptor blockers/angiotensin-converting enzyme inhibitors,0,0,0,1,0,1
swab,0,0,0,1,0,1
sweat samples (covidog ancillary study),0,0,0,1,0,1
symbicort,0,0,0,1,0,1
symptom survey,0,0,0,1,0,1
symptomatic drugs,0,0,0,1,0,1
symptomatic treatment,1,0,0,0,0,1
symptomatic treatment (paracetamol,0,0,0,1,0,1
symptomatic treatment (paracetamol),0,0,0,1,0,1
symptomatic treatment (paracetamol/best symptomatic treatment based on doctor recommendations),0,0,0,1,0,1
synthetic neutralising antibodies,0,0,0,1,0,1
t-cell receptor,0,0,0,1,0,1
t cell derived exosom,1,0,0,0,0,1
t memory cells,0,0,0,1,0,1
t memory cells/nk cells,0,0,0,1,0,1
t3 solution,0,0,0,1,0,1
tablets,1,0,0,0,0,1
tafenoquine oral tablet,0,0,0,1,0,1
tailored best practices,0,0,0,1,0,1
tailored recommendations,0,0,0,1,0,1
tak-019,0,0,0,1,0,1
tak-919,1,0,0,0,0,1
tape-software,0,0,0,1,0,1
targeted message,0,0,0,1,0,1
tazobactam,0,0,0,1,0,1
tcc-covid mhealth,0,0,0,1,0,1
td139,0,0,0,1,0,1
technology based social interactions,0,0,1,0,0,1
tele-delivered psychological intervention,0,0,0,1,0,1
tele-interventions related to diabetes management,0,1,0,0,0,1
tele-interventions related to diabetes management/mental well-being,0,1,0,0,0,1
telegeriatric intervention,0,1,0,0,0,1
telehealth monitoring,0,0,0,1,0,1
telehealth/counselling,1,0,0,0,0,1
telemedicine visit,0,0,0,1,0,1
telemonitoring,0,0,0,1,0,1
telemonitoring/teleorientation,0,0,0,1,0,1
teleorientation,0,0,0,1,0,1
telephone follow-up,1,0,0,0,0,1
telepsychoeducation,0,0,1,0,0,1
telepsychoeducation with personalized videos,0,0,1,0,0,1
telepsychoeducation without personalized videos,0,0,1,0,0,1
telesimulation,0,0,0,1,0,1
telmisartan 40mg oral tablet,0,0,0,1,0,1
tenecteplase,0,0,0,1,0,1
tenofovir,0,0,0,1,0,1
tenofovir disoproxil/emtricitabine,0,0,0,1,0,1
tenofovir disoproxyl fumarate 300 mg,0,0,0,1,0,1
tenofovir disoproxyl fumarate 300 mg oral tablet,0,0,0,1,0,1
tenofovir disoproxyl fumarate 300 mg/emtricitabine 200 mg oral tablet,0,0,0,1,0,1
tensile strength,0,1,0,0,0,1
test group: experimental - uvc therapy applied,1,0,0,0,0,1
test rt-pcr,0,1,0,0,0,1
testis pathology samples,0,0,0,1,0,1
tetracycline hydrochloride 3%,0,0,0,1,0,1
tetrandrine,0,0,1,0,0,1
text material for psychoeducation,0,0,0,1,0,1
text material for psychoeducation/audio for relaxation techniques,0,0,0,1,0,1
the management of severe covid-19 cases,1,0,0,0,0,1
the psychosocial effects of covid-19 pandemic on dental professionals,0,1,0,0,0,1
the standard protocol only,0,0,0,1,0,1
the use of the mentalplusâ® digital game for assessment,0,0,0,1,0,1
the use of the mentalplusâ® digital game for assessment/rehabilitation of cognitive function after remission of the symptoms of covid-19,0,0,0,1,0,1
therapeutic exercise,0,0,1,0,0,1
therapeutic exercise/education,0,0,1,0,0,1
theraputic heparin,0,0,0,1,0,1
therapy intervention,0,1,0,0,0,1
"three doses of high-dose recombinant sars-cov-2 vaccine (cho cell) at the schedule of day 0, 14, 28",0,0,0,1,0,1
"three doses of high-dose recombinant sars-cov-2 vaccine (sf9 cell) at the schedule of day 0, 14, 28",1,0,0,0,0,1
"three doses of middle-dose recombinant sars-cov-2 vaccine (cho cell) at the schedule of day 0, 14, 28",0,0,0,1,0,1
"three doses of placebo at the schedule of day 0, 14, 28 #high-dose group#",0,0,0,1,0,1
"three doses of placebo at the schedule of day 0, 14, 28 #middle-dose group#",0,0,0,1,0,1
throat,0,0,0,1,0,1
throat swab,0,0,0,1,0,1
thymic peptides,0,0,0,1,0,1
thymosin,0,0,0,1,0,1
tigeraseâ®,0,1,0,0,0,1
tigeraseâ®/best available care,0,1,0,0,0,1
tinzaparin,0,0,0,1,0,1
tirofiban,0,1,0,0,0,1
tj003234,0,0,0,1,0,1
tm5614,0,0,0,1,0,1
tnkase,1,0,0,0,0,1
tociliuzumab,0,1,0,0,0,1
tocilizumab 20 mg/ml intravenous solution [actemra]_#1,0,0,0,1,0,1
tocilizumab 20 mg/ml intravenous solution [actemra]_#1 (2 doses),0,0,0,1,0,1
tr,0,0,0,1,0,1
tracheotomy,0,0,0,1,0,1
tradipitant,0,0,1,0,0,1
traditional chinese medicine,0,0,0,1,0,1
traditional proning arm,0,0,0,1,0,1
training clinicians in basic critical care,1,0,0,0,0,1
training clinicians in basic critical care/the management of severe covid-19 cases,1,0,0,0,0,1
"training for awareness, resilience,",0,1,0,0,0,1
"training for awareness, resilience,/action (tara)",0,1,0,0,0,1
"training of youth, community health assistants",1,0,0,0,0,1
"training of youth, community health assistants/community health workers.",1,0,0,0,0,1
training session adressing information,0,0,0,1,0,1
training session adressing information/health literacy,0,0,0,1,0,1
tranexamic acid,0,0,0,1,0,1
trans sodium crocetinate,0,0,0,1,0,1
transcendental meditation,0,0,0,1,0,1
transcranial direct current stimulation,0,0,0,1,0,1
transcutaneous auricular vagus nerve stimulation,0,0,0,1,0,1
transfer package from ci therapy,0,0,0,1,0,1
transfusion of sars-cov-2 convalescent plasma.,0,0,0,1,0,1
transfusion of standard plasma.,0,0,0,1,0,1
transpulmonary pressure measurements,0,0,0,1,0,1
trauma-informed yoga video recording,0,0,0,1,0,1
trauma informed psychotherapy,1,0,0,0,0,1
trauma informed yoga,1,0,0,0,0,1
travelan otc,1,0,0,0,0,1
treamid,1,0,0,0,0,1
treated with hyperimmune plasma,0,0,0,1,0,1
treatment,0,1,0,0,0,1
treatment as usual vitamin d,0,0,0,1,0,1
treatment/prophylaxis,0,1,0,0,0,1
triazavirin (riamilovir),0,0,0,1,0,1
tridecactide,0,1,0,0,0,1
trimetazidine,0,0,0,1,0,1
trimodulin,0,0,0,1,0,1
trimoxazole,0,0,0,1,0,1
trust in science message,0,1,0,0,0,1
trv027,0,0,0,1,0,1
tsu,0,0,0,1,0,1
tsvf,0,0,0,1,0,1
two covid-19 vaccine candidate (tmv-083) administrations - high dose,0,0,0,1,0,1
two covid-19 vaccine candidate (tmv-083) administrations - low dose,0,0,0,1,0,1
two dose chadox1 ncov-19/covishield 0.25ml/0.5ml,0,0,0,1,0,1
two dose chadox1 ncov-19/covishield 0.5ml,0,0,0,1,0,1
two dose menacwy vaccine min. 4 weeks apart,0,0,0,1,0,1
"two doses of commercial scale inactivated sars-cov-2 vaccine at the schedule of day 0,14",0,0,0,1,0,1
"two doses of high-dose recombinant sars-cov-2 vaccine (cho cell) at the schedule of day 0, 14",0,0,0,1,0,1
"two doses of high-dose recombinant sars-cov-2 vaccine (sf9 cell) at the schedule of day 0, 28",1,0,0,0,0,1
"two doses of high dosage inactivated sars-cov-2 vaccine at the schedule of day 0,28",1,0,0,0,0,1
"two doses of middle-dose recombinant sars-cov-2 vaccine (cho cell) at the schedule of day 0, 14",0,0,0,1,0,1
"two doses of middle-dose recombinant sars-cov-2 vaccine (sf9 cell) at the schedule of day 0, 28",1,0,0,0,0,1
"two doses of pilot scale inactivated sars-cov-2 vaccine at the schedule of day 0,14",0,0,0,1,0,1
"two doses of pilot scale inactivated sars-cov-2 vaccine at the schedule of day 0,14 in elderly",0,0,0,1,0,1
"two doses of placebo at the schedule of day 0, 14 #high-dose group#",0,0,0,1,0,1
"two doses of placebo at the schedule of day 0, 14 #middle-dose group#",0,0,0,1,0,1
txa127,0,0,0,1,0,1
ultra-micronized palmitoylethanolamide (mpea,0,0,0,1,0,1
ultra brief online mindfulness-based intervention,0,1,0,0,0,1
ultraprotective ventilation,0,0,0,1,0,1
umifenovir,0,0,1,0,0,1
"umpea, 300mg",0,0,0,1,0,1
unavailable covid test result - hypothetical scenario,0,1,0,0,0,1
unfractionated heparin iv,0,0,0,1,0,1
unfractionated heparin sc,0,0,0,1,0,1
uni911 inhalation,1,0,0,0,0,1
unified protocol for covid-19 parenting stress (up-covid),0,1,0,0,0,1
unsupervised physical activities,0,0,0,1,0,1
urine samples,0,0,0,1,0,1
usability,0,0,0,1,0,1
use of facetime with child,0,0,0,1,0,1
use of facetime with child/parents during induction,0,0,0,1,0,1
usual antibiotic treatment,0,0,0,1,0,1
usual care control,0,0,0,1,0,1
usual care only,0,0,0,1,0,1
usual care positioning with no instructions,0,0,0,0,1,1
usual monitoring,0,0,0,1,0,1
usual orientations,0,0,0,1,0,1
usual practice / symbicort rapihaler,0,0,0,1,0,1
utooth btc),0,0,0,1,0,1
uttr1147a,0,1,0,0,0,1
uv light treatment,0,1,0,0,0,1
v-sars,1,0,0,0,0,1
v hydrogen peroxide,0,0,0,1,0,1
v povidone-iodide,0,0,0,1,0,1
v) saline,1,0,0,0,0,1
v590,0,0,0,0,1,1
v591,0,0,0,0,1,1
vaccinated with polio vaccine (ipv),0,0,0,1,0,1
vaccine therapy,0,0,0,1,0,1
vaccine: recombinant new coronavirus vaccine (cho cell) low-dose group,1,0,0,0,0,1
vaccine: recombinant new coronavirus vaccine (cho cells) high-dose group,1,0,0,0,0,1
vadadustat,0,0,0,1,0,1
vb-201,0,0,0,1,0,1
vb-201 / standard of care,0,0,0,1,0,1
vcpm,0,0,0,1,0,1
vehicle,0,1,0,0,0,1
vehicle / heparin along with best supportive care,0,1,0,0,0,1
venous draw,0,0,0,1,0,1
venous draw/testing,0,0,0,1,0,1
ventaprost (inhaled epoprostenol delivered via a dedicated delivery system),0,0,0,1,0,1
verapamil,0,0,0,1,0,1
veru-111,1,0,0,0,0,1
vesta respirator,0,0,0,1,0,1
vib7734,0,0,0,1,0,1
vibrolung,0,0,0,1,0,1
video-based intervention,0,0,0,1,0,1
video chat / basic feedback,1,0,0,0,0,1
video chat /personalized feedback,1,0,0,0,0,1
video dance classes,0,0,0,1,0,1
vielight rx plus,0,0,0,1,0,1
vir-7831 (gen1),0,0,0,1,0,1
vir-7831 (gen2),0,0,0,1,0,1
virgin coconut oil (vco),0,0,0,1,0,1
virtual-care cognitive behavioural therapy,0,0,0,1,0,1
"virtual assistant first, then human coach",0,0,0,1,0,1
virtual care at home,0,0,0,1,0,1
virtual elm,1,0,0,0,0,1
virtual family-based treatment,0,0,1,0,0,1
virtual group exercise,0,0,0,1,0,1
virtual group intervention,0,1,0,0,0,1
virtual reality,0,0,0,1,0,1
virtual reality therapy first,1,0,0,0,0,1
viruxal oral,0,0,0,1,0,1
viruxal oral/nasal spray,0,0,0,1,0,1
vitamin b,0,0,0,1,0,1
vitamin c 500 mg oral tablet,0,0,0,1,0,1
vitamin c tablets,0,0,0,1,0,1
vitamin e,1,0,0,0,0,1
vitamin k2 in the form of menaquinone-7 (mk-7),0,0,0,1,0,1
vitamine d3 supplementation,0,0,0,0,1,1
vitamins,0,0,0,1,0,1
viusid/asbrip,0,1,0,0,0,1
vla2001,1,0,0,0,0,1
voclosporin,0,0,0,1,0,1
volatile organic compounds analysis (e-noses),0,0,0,1,0,1
volatile organic compounds analysis (mass spectrometry),0,0,0,1,0,1
volatile organic compounds analysis in sweat (mass spectrometry),0,0,0,1,0,1
vr for psychoeducation,0,0,0,1,0,1
vr for psychoeducation/relaxation,0,0,0,1,0,1
vv-ecmo / cytokine adsorption,0,1,0,0,0,1
vxa-cov2-1,1,0,0,0,0,1
ward css,0,0,0,1,0,1
water (e) mouth rinse with the solution provided,0,0,0,1,0,1
water without an elevated level of kelea,0,0,0,1,0,1
wearing surgical face mask sprayed with hypertonic saline,0,0,0,1,0,1
webex physical activity program,0,0,0,1,0,1
weekly assessment,0,0,0,0,1,1
wellness education,0,1,0,0,0,1
wfi water nebulization,0,0,0,1,0,1
wharton's jelly derived mesenchymal stem cells.,0,0,0,1,0,1
white sender in acknowledgement,1,0,0,0,0,1
white sender in informational videos,1,0,0,0,0,1
who recommendations (waiting condition),0,0,0,1,0,1
withings scanwatch,0,0,0,1,0,1
woebot substance use disorder,0,1,0,0,0,1
wofb,0,0,0,1,0,1
written summary of rounds,0,0,0,1,0,1
xav-19,0,0,0,1,0,1
xc221,0,1,0,0,0,1
xcel-umc-beta,0,0,0,1,0,1
xuanfei baidu granules,0,0,0,1,0,1
yoga group,0,1,0,0,0,1
zanubrutinib,1,0,0,0,0,1
zavegepant (bhv-3500),0,0,0,1,0,1
zidovudine,0,1,0,0,0,1
zilucoplan,0,0,0,1,0,1
zilucoplan placebo,0,0,0,1,0,1
zinc acetate,0,0,0,1,0,1
zinc citrate,0,0,0,1,0,1
zinc picolinate,1,0,0,0,0,1
zinc sulfate 220 mg,0,1,0,0,0,1
zithromax,0,0,0,1,0,1
zofin,0,0,0,1,0,1
